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ZUSAMMENFASSUNG
1 ZUSAMMENFASSUNG
Die quergestreifte Muskulatur besteht aus hoch organisierten Strukturen mit dem Sarkomer 
als kleinste kontraktile Einheit. Um effiziente Muskelfunktion zu ermöglichen, ist ein 
exakter Aufbau dieser Strukturen essentiell. Die zellulären Prozesse die notwendig sind 
um den präzise Sarkomerbildung zu ermöglichen, sowie deren regulatorische Abläufe 
sind bislang nur unvollständig verstanden. Um einen derart komplexen Vorgang im Detail 
verstehen zu können, müssten alle beitragenden Faktoren bekannt sein.  Mit dem Ziel 
bisher unbekannte Faktoren zu erfassen, wurde ein komplexer Screen entwickelt, mit dem 
neuartige Gene identifiziert werden können, die in der quergestreifte Muskulatur exprimiert 
werden und im Laufe der Evolution konserviert wurden und somit höchst wahrscheinlich 
eine wichtige Rolle für den Muskel darstellen. Die ermittelten Gene besitzen derzeit 
keine beschriebene Funktion im Bereich der Muskel Funktion. Ein Kandidat dieser 
neuartigen Gruppe ist leucine-rich repeat containing protein 39, kurz LRRC39. Ziel dieser 
Arbeit ist es dieses Gen zu charakterisieren und deren Bedeutung für die Muskulatur zu 
untersuchen. Mittels Expressionsstudien konnte die Lokalisation von LRRC39 im Herz-, 
sowie im Skelettmuskel bestätigt werden. Sie subzelluläre Lokalisation diese Proteins 
wurde im Bereich der sarcomerischen M-bande detektiert. Um eine mögliche funktionelle 
Rolle dieses Genes zu adressieren, wurden sogenannte loss-of-function-Experimente im 
Zebrabärblingsmodell durgeführt und resultierten in veränderten herzstrukturen und 
deformierter Skelettmuskulatur. Diese Beobachtungenweisen auf eine wichtige Bedeutung 
für die Muskelentwicklung lieferten. Detailierte Untersuchungen der Ultrastruktur des 
Skelettmuskels mittels Elektronenmikroskopie zeigten strukturelle Veränderungen in 
der Sarkomerorganisation. Um Einblick in den Entstehungsprozess dieses Phänotyps zu 
gewinnen, wurden Proteinexpressionsstudien mittels Massenspektrometrie durchgeführt, 
die drastische Veränderungen substanzieller Proteine der Sarkomerassemblierung zeigten. 
Um  die primäre Rolle von Lrrc39 auf molekularer Ebende zu untersuchen, wurden Protein-
Protein Interaktionsstudien durchgeführt, welche die α-helikale Region der Myosin 
schweren Ketten (MHC) als Bindungspartner identifizierten. Obgleich die Kopfdomäne 
der Myosine, mit ihrer kennzeichnenden Motorfunktion für die Muskelkontraktion 
intensiv beforscht wurde, sind die Eigenschaften der α-helikalen Region des Myosins nur 
wenig verstanden. Die Interaktion von Lrrc39 mit diesem Bereich des Myosins wurde in 
weiterführenden Experimenten untersucht und weist auf einen möglichen regulatorischen 
Einfluss von Lrrc39 auf MHC Proteine durch veränderte Phosphorylierung hin. Auch 
wenn der Mechanismus dieser Interaktion im zentralen Bereich des Sarkomers nicht 
final geklärt werden konnte, zeigen die Ergebnisse dieser Studie Lrrc39 als wichtigen 
Faktor in der Sarkomerassemblierung, möglicherweise durch Regulation der Myosin 
Funktion. Zusammenfassend konnte in dieser Arbeit ein neuartiges Protein des Sarkomers 
beschrieben werden, welches eine bedeutende Funktion in der Organisation der Sarkomere 
einnimmt.
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2 ABSTRACT
The cross-striated musculature consists of highly organised structures with the sarcomere 
as the basic contractile unit. To allow efficient muscle function, exact formation of these 
structures is essential. The cellular processes, which are necessary to enable precise 
sarcomere organisation and their regulatory sequence of events, are not completely 
understood. In order to elucidate such complex processes in detail, all involved factors 
ought to be known. Aiming at the determination of previously unknown factors, a 
highly organised screening procedure has been developed to identify novel genes with 
still uncharacterised function in the striated muscle development. These genes were 
evolutionary conserved and foreseen to be expressed in the striated musculature, which 
suggested an important role for muscle function. One interesting candidate among 
them is the leucine-rich repeat containing protein 39 (LRRC39). This study is aimed to 
characterise this gene and analyses its impact on muscle functions. The data presented 
in this dissertation confirmed the expression patterns of LRRC39 in the heart and the 
skeletal muscle in model organisms. To address potential functions of this gene, loss- 
experiments in zebrafish were conducted. As result, deformations in the heart structure and 
skeletal muscle tissue were observed to indicate the importance of Lrrc39 for the muscle 
development of zebrafish. By electron microscopy, the disturbed sarcomere organisation 
of the zebrafish skeletal muscle was revealed to firmly confirm the functional role of 
Lrrc39. To elucidate the mechanisms behind the observed phenotypes upon the reduction 
of Lrrc39, transcriptomics and proteomics techniques were employed. A careful profiling 
by mass spectrometry was conducted, which showed drastic changes of essential proteins 
for the sarcomere assembly. Furthermore, subcellular localisation studies and protein-
protein interaction analysis were conducted to identify the α-helical tail region of the 
well-known structure proteins myosin heavy chain (MHC) as interaction partners of 
LRRC39. 
Over the years of researches in the field of muscle development and function revealed 
the importance of the head domain of MHC proteins in regards to their motor activity 
for muscle contraction. However, the properties of the α-helical tail region are less well-
understood. To address this point, a set of experiments were performed to suggest the 
possible involvement of LRRC39 to the regulation of MHC proteins through altered 
phosphorylation patterns of MHC.  This suggests a link between the sarcomere assembly 
and muscle contraction in the context of LRRC39 and MHC proteins. In sum, this study 
presented a novel protein of the sarcomere with its vital function for the sarcomere 
organisation.
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INTRODUCTION
„Dem Anwenden muss das Erkennen vorausgehen“ 
“Insight must precede application“
Max Planck
3 INTRODUCTION
The striated musculature is essential for any voluntary movements, as well as for a regular 
and powerful heartbeat. In order to assure this reliable and high-quality force production, 
not only the major structural proteins (e.g. actin, myosin and titin) but also proteins 
to regulate and control the appropriate contraction are needed. Additional proteins are 
necessary to set the orientation, to give stability by connecting to other proteins, to sense 
extracellular signals and to transport this information. Furthermore, it is a generally 
accepted view that muscle fibres do not increase in number (hyperplasia) after birth and 
therefore, a physiological replacement of the complete fibres seems unlikely. However, 
in order to maintain their functions, the frequently-used structural proteins have to be 
replaced constantly and in a timely manner. This requires a well organised turnover of 
structural proteins within the muscle cells. To maintain such functions, the force-producing 
muscle requires a complex network of events, which is not yet understood completely. 
Therefore, functional analysis of involved genes might help to understand the muscle 
function in detail. 
Although many genomes are sequenced and protein coding sequences are known, their 
function still remains uncharacterised. Data from high-throughput screenings showing 
evidence for a large number of genes without any documented functions. In the human 
genome for example, approximately 37% of the genes are functionally not annotated 
(Wren, 2009). The constantly increasing amount of results from high-throughput 
technologies showing evidence for a relatively high number of uncharacterised genes, 
but even if these genes show tissue specificity or changes in their expression patterns 
in different organs and/or under a particular condition (e.g. hypertrophy), they are often 
removed from further analysis (Pawlowski, 2008). For this reason, a systematic way to 
characterise these genes is needed in order to identify novel key players of the tightly 
regulated processes of the musculature. 
The first part of the introduction focuses on the structural and functional role of the striated 
muscle and illuminates some open research questions. The second part demonstrates one 
way to identify and annotate novel genes in order to create a better understanding of the 
complex muscle function.
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3.1 Structure and function of the striated musculature
The musculature is an efficient and very precise tool with a complex cytoskeletal network, 
and from its contractile activity, it is regarded as the force-generating machinery of our 
body. The functional outcome of a muscle cell is always the same:  Force. 
In vertebrates, three main force productive cell types can be distinguished:  smooth 
muscle, skeletal muscle and cardiac muscle (Brenner, 2010). Although the development 
of the heart and the skeletal muscle as well as their localisation and their conductive 
system are fundamentally different, the basic structures of cardiac and skeletal muscle 
are highly similar. These two cell types are composed of parallel arranged myofibrils, 
containing repetitive units of overlapping structural filaments and motor proteins, which 
leads to a cross-striated appearance at the microscopic level. Over the last decades, 
researches based on transcription factors and their regulation, have been very successful 
in elucidating components important for muscle differentiation and  fuction. However, 
the initial process that forms the contractile units is less understood. 
3.1.1 Architecture of the striated muscle
Cardiac and skeletal muscle are characterised by their regular cross striation, which 
can be visualised at the microscopic level. This feature is the result of their behaviour 
under polarised light. Isotropic regions, the so called I-bands, appear lighter and are 
alternating with anisotropic structures, called A-bands, which are comparably darker in 
their appearance (Hanson and Huxley, 1953). As shown in Figure 1, the I-band is divided 
by the dark appearing Z-line. The A-band contains a centralised lighter region, which 
is composed of the H-zone with the dark appearing M-band in the centre. The repeated 
alternations of these structures are aligned longitudinally to the fibre orientation, which 
lead to the observed cross striation. The muscle fibre consists of bundled myofibrils, 
which are composed of small repetitive subunits. The smallest functional subunit of the 
myofibril is the sarcomere, which is defined as the segment between two Z-lines (Ehler 
and Gautel, 2008). The sarcomere contains the three main protein filament systems:  (1) 
The thin filament, which contains mainly actin, tropomyosin and troponin; (2) the thick 
filament, which holds predominantly myosins and (3) the giant protein titin that spans the 
half of sarcomere length from the Z-line to the M-band. Thin and thick filaments align 
parallel in a conserved hexagonal orientation at the distal regions of the A-band as shown 
in Figure 1B. This overlap is necessary for the formation of the cross bridges, which form 
the core for the contraction. The single filament systems are described in the following 
subsections.
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The thick filament 
The thick filament consists predominantly of myosins. This large family consists of 
approximately 140 myosins and can be grouped by sequence analysis into seventeen 
distinct classes (Korn, 2000). The different classes generally vary in their properties at 
the amino-terminal head domain that is involved in diverse cellular processes, such as 
migration, adhesion, intracellular transport and signal transduction (Krendel and 
Figure 1: Composition of the striated muscle. Scheme of the skeletal muscle structure (modified from 
Bloom and Fawcett, 1975; Myhre and Pilgrim, 2012); A: Schematic view of the sarcomere (modified from 
Gregorio, 1999); C: Electron microscopy image of longitudinal section of a skeletal muscle myofibril 
showing one sarcomere bordered by two Z-lines (taken from H.E. Huxley 1958); D: Scheme of the 
sarcomere structure in transversal view showing hexagonal orientation. modified from (H.E. Huxley, 1958).
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Mooseker, 2005). The sarcomere contains class II myosins that take up about 40-50% 
of the total muscle proteins. The members of class II myosins vary mainly in their tissue 
specificity and ATPase activity (Clark, 2007). Myosin-1 (MYH1) as well as myosin-2 
(MYH2) and myosin-4 (MYH4) are predominantly expressed in the adult skeletal muscle, 
whereas MYH3 is found in embryonic muscle. Furthermore, MYH8 is expressed in the 
perinatal skeletal muscle. The amount and distribution of these genes vary in different 
muscle cell types (e.g. slow versus fast fibre type) (Allen, 2000). In the adult heart, MYH6 
(also known as α-MHC) and MYH7 (also known as β-MHC) are found. The expression 
patterns and the tissue specificities of these myosins are evolutionary conserved. 
Alteration in these specifications can lead to pathological changes. The ablation of MYH6 
in mice, for example, was shown to be lethal (Jones, 1996). The homozygous mice died 
of severe cardiac defects around embryonic day 12. The surviving heterozygous offspring 
developed dramatic cardiac abnormalities, suggesting that MYH7 cannot compensate 
the loss of its family member. Similar observations were shown in mice carrying null 
mutations in distinct adult skeletal muscle myosin isoforms. These mice have a decreased 
muscle mass and show substantial alterations in the skeletal muscle morphology (Allen, 
2000). Consequently, this class of myosins appear to be functionally diverse, rather than 
functionally redundant. 
Although species and fibre type specific differences of the musculature exist, the 
molecular structure of the class II myosin is highly conserved. Members of the class 
II myosin are characterised by four myosin light chains (each around 20 kDa), which 
are further subdivided into two essential- and two regulatory light chains, and by two 
myosin heavy chains (MHC) of around 200 kDa. The heavy chains form globular heads 
at the amino-terminal regions of myosin. This head region has a dimension of 165x 65 
x 40 Å and acts through their actin binding and ATPase activity to provide the motor of 
muscle contraction. The two heavy chains form a α-helical coiled-coil structure at the 
carboxy-terminal region of 1600 Å in length, which is termed the rod domain. A repetitive 
sequence of seven amino acids within the myosin heavy chain builds a hydrophobic core, 
which is surrounded by alternating positive and negative charged chains at the surface of 
the structure.  An additional repetitive region of 196 amino acids creates one turn of 14.3 
nm in length. These arrangements cause a stable coiled-coil structure of the two myosin 
heavy chains with a diameter of 20 Å (Sjostrom and Squire, 1977a;  McLachlan and Karn, 
1982). Myosin can be further separated by enzymatic digestion in the heavy meromyosin 
fragment (HMM) and the α-helical rod part termed light meromyosin (LMM), as shown 
in Figure 2A. The HMM part contains the two heads (S1) and a part of the α-helical 
myosin heavy chain, which is called S2 domain. The LMM fragment, which contains 
the main part of the rod domain is essential for the stable construction of the myosin 
filaments. The three fragments are connected through so-called hinge regions at the S1/S2 
16
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Under normal physiological condition, myosin II molecules arrange spontaneously in 
filaments and form later the A-band of the sarcomere (Srikakulam and Winkelmann, 
2004). During the myosin assembly, several proteins were identified to be involved in the 
organisation of this process (reviewed in Wang, 1998;  Ehler and Gautel, 2008).  Before 
the actual assembly initiates, myosin molecules need to be folded to their hexameric 
structure mentioned above. During the folding process, a complex of chaperones were 
identified to play a major role, including HSP70 and HSP90 (Srikakulam and Winkelmann, 
2004) and a member of the UCS-domain containing family, UNC-45. These proteins 
interact with each other to regulate proper myosin arrangement.  The signalling pathways 
of this complex are yet to be elucidated. However, loss of function studies resulted in 
abnormalities in myofibrillar organisation, including myosin aggregation, which support 
the important roles of these chaperones (Barral, 2002;  Landsverk, 2007;  Wohlgemuth, 
2007). Once the myosin molecules are properly folded, they align to a bundled structure, 
with their C-termini associate with each other and build the final filament as illustrated in 
Figure 2B.  
LMMHMM
S2
S1
S1
A
B
M-line
bare zone
P-zoneC-zoneD-zone P-zone C-zone D-zone
A-band
C
Figure 2: Scheme of the class II muscle myosin. A: Hexameric myosin molecule and their defined regions: 
HMM (heavy meromyosin) with S1 (the myosin heads) and S2 (first part of the a-helical heavy chain) and 
LMM (light meromyosin) (based on Zoghbi, 2008). B: Schematic view of the thick filament, representing 
the A-band and indicates the different defined areas of the myosin filament. C: From the M-line that marks 
the centre towards the distal ends, the regions are further divided into bare zone, P-zone, C-zone and 
D-zone (based on Sjostrom and Squire, 1977b; McLachlan and Karn, 1982).
and at the S2/LMM junction. These joints are important for the orientation of the myosin 
heads, which bind  to the thin filament  (H.E. Huxley, 1969).
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The anti-parallel organisation in the centre of the filament leads to an overlap of rod 
domain of the myosins, which forms the M-region. This region, also known as “bare 
zone”, lacks myosin heads due to the bipolarity of myosins, which are targeting towards 
opposite directions. The central part of the bare zone shows electron dense structures, 
which appear in electron microscopy as a dark line of approximately 100 nm width.  The 
M-band serves as the primary anchor point for the thick filament. The thick filament 
contains 294 myosin molecules and has a precise length of 1.59 µm (McLachlan 
and Karn, 1982). The different defined areas within the thick filament are illustrated 
Figure 2C.  The bare zone measures around 1600 Å in length (Al-Khayat, 2008). As 
mentioned above, the bare zone contains only the myosin rod part; thus, it is unable 
to form any myosin cross bridges. The first myosin heads appear with the start of the 
P-zone, which is neighbouring the bare zone. At a distance of 2040 Å, the C-zone starts, 
which is followed by a cylindrical ending area called the “D-zone” (Sjostrom and Squire, 
1977b).  These clearly defined zones are based on detailed structural analyses and not 
on their functionalities. Nevertheless, expression analysis for myosin binding protein-C 
(MyBP-C), which is located in the C-zone, verified this classification (Craig and Offer, 
1976;  Gilbert, 1999;  Winegrad, 2003). Myosin binding protein C (MyBP-C) is localised 
in seven to nine stripes in the C-region of the A-band (Luther, 2008). After targeted gene 
knockout in mice, lack of MyBP-C resulted in dilated cardiomyopathy (McConnell, 1999) 
or hypertrophic cardiomyopathy, sudden death and reduced exercise capacity (Harris, 
2002). The severity of the observed phenotypes proves the importance of these zones for 
the muscle. However, the mechanism of MyBP-C function is not understood in detail.
In the central part of the thick filament, additional proteins are identified. A detailed 
microscopic analysis of the M-band revealed five prominent M-lines with a distance of 
about 22 nm.  The number of lines can vary dependent on the species and fibre type. 
It was suggested that the line density correlates with the physiological performance of 
different muscle types (Sjostrom and Squire, 1977a;  Thornell, 1987). The appearance 
in cardiac sarcomeres, for example, correlates with the beating rate in different species. 
In extreme cases, like in embryonic heart and extraocular muscle, the sarcomere do not 
show an electron dense M-band (Pask, 1994;  Smolich, 1995). Most common form of the 
M-band is the presence of five separate lines, defined as M1 in the centre, surrounded by 
M4, M4’, M6 and M6’. Although the lines are clearly detectable, corresponding proteins 
building these lines are not fully identified. Until now, the muscle-type creatine kinase 
(MM-CK), which is one of the key enzymes in the cellular energy supply, and myomesin 
(MYOM) have been found in this defined region (van der Ven, 1996;  Hornemann, 2003). 
The MM-CK was detected by immunhistological stainings to be localised in the M4-
lines (Wallimann, 1983). The myomesins were initially described by Eppenberger and 
colleagues in 1984. They identified a 165 kDa protein, which they named M-protein 
(MYOM2) and a 185 kDa protein called myomesin (MYOM1). Both proteins are localised 
18
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in the M-band  (Grove, 1984). Furthermore, it was shown that myomesin dimerises and 
crosslinks myosin filamtents at the M-band (Lange, 2005b). This connection between 
myomesin and myosin forms a solid structure at the M-band and is thought to stabilise the 
thick filaments (Agarkova, 2003). A similar interaction was observed between skelemin 
(EH-myomesin) and M-protein, which are later identified to be homologs of myomesin 
(Masaki and Takaiti, 1974;  Steiner, 1999). 
Due to the lack of known annotated proteins in the M-band, the functional characterisation 
of this specific region still remains unclear. Based on microscopic observations, this 
structure seems essential for regular packing of the myosin filaments (Knappeis and 
Carlsen, 1968). This aspect is supported by a novel three-dimensional model by Lange 
and colleagues, which was developed based on interaction studies of myomesin, titin and 
myosin (Lange, 2005b).  The M-band serves not only as an anchor for myosin filaments 
but participates as a structural component in the maintenance of the A-band lattice (Luther, 
1981). During active muscle movements, it contributes to the distribution of mechanical 
stress across the lattice. In the recent years, an interest into uncovering the function of the 
M-band has increased. Additional constituents of the M-band were identified to interact 
with the thick filament and thereby regulating muscle function. These include MURFs, 
a group of muscle specific RING finger proteins. Through their ubiquitin ligase activity, 
they are implicated in diverse processes, including ubiqutination and transcriptional 
regulation. In the same context the protein Nbr1 (neighbor of BRCA1 gene 1) was 
identified (Perera, 2011). Other M-band related proteins are Obscurin (Fukuzawa, 2008), 
the Muscle LIM protein (MLP) (Ehler, 2001;  Lange, 2005a) and Calpain 3 (Sarparanta, 
2010). Calpain 3 (also known as p94) is a calcium-dependent protease (Roperto, 2010) 
that interacts with the M-band region of titin and is associated with muscular dystrophy 
(Y. Ono, 1999;  Haravuori, 2001). The latest results suggest that this structure in the 
centre of the sarcomere is not only important for the stability but can actively regulate 
sarcomere function. These additionally identified proteins are currently investigated 
further to provide a better understanding of the organisation and function of this filament.
The thin filament
The main component of the thin filament is actin. This well-known structural protein has a 
molecular weight of 42 kDa and is ubiquitously expressed. It is involved in diverse cellular 
functions, such as motility and cytokinesis. In the striated muscle, actin filaments are 
comprised of globular actin molecules (G-Actin), which polymerise to filamentous actin 
(F-actin) and form polar, α-helical structures. Likewise myosin assembly, the chaperones 
Hsp70/ Hsp90 are important for proper folding and formation of actin. Additionally, the 
proteins GimC (Siegers, 1999) and TRiC (Grantham, 2002) are 
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involved. However, the precise mechanism of actin folding and its assembly is unclear. 
In isolated conditions, actin is able to self-assemble and forms filamentous structures, 
the F-actin. However under physiological conditions, many proteins are associated with 
this process and regulate thin filament assembly. These proteins have been described 
to add or exchange actin monomeres either at their C-terminal end, the barbed end or 
at their N-terminal, the pointed end (S. Ono, 2007). Tropomodulin (TMOD) binds the 
pointed ends and thereby protects the thin filament from polymerisation and accordingly 
depolymerisation (Broschat, 1990;  Yamashiro, 2008).  Other proteins at the same actin 
terminus are Leiomodin (LMOD), which leads after inhibition to severe changes in actin 
filament assembly (Chereau, 2008) and cofilin (CFL) (Van Troys, 2008). On the other 
site of the structure, CAPZ (capping protein muscle Z-line) binds to the barbed ends and 
inhibits actin polymerisation (Pappas, 2008). Expression analyses in cultured chicken 
cardiomyocytes identified an additional protein, N-RAP, to regulate the linkage between 
two barbed ends (Carroll, 2004). Through the binding of these proteins the length of actin 
filaments is controlled (reviewed in (Cooper and Schafer, 2000). 
In its final form, actin filament is ~1 µm in length and has a diameter of approximately 7 
nm. On its surface, myosin binding sites are positioned in order to connect thin filament to 
the thick filament. These sites are present in an interval of 2.7 nm. For this actin-myosin 
interaction, the actin-binding proteins tropomyosin (Tm) and troponins (Tn) are essential. 
Tm consists of two α-helical chains that integrate between the grooves of the α-helial 
actin filaments (Gordon, 2000). In this position, Tm stabilises the filament structure but 
also blocks the myosin-head binding sides on the surface of the thin filament. Through 
calcium-dependent activation of the nearby troponin complex, which consists of three 
subunits (TnI, TnC and TnT), Tm is shifted in its position and exposes the myosin binding 
sides (Herzberg and James, 1985). This important movement permits muscle contraction 
and will be described in the later section. Apart from the crucial role in contraction, 
the thin filament is essential for the sarcomere formation. The barbed ends of the polar 
structure are bound to α-actinin and crosslink at the Z-band. The rest of the filament 
extends with the pointed end in the direction of the M-band. Through intermediate 
filaments like desmin (DES) and Merosin, and adapter proteins like dystrophin (DMD) 
and vinculin (VCL), which  are positioned at the Z-band, actin filaments are connected 
to the plasma membrane and neighbouring filament systems (Winder and Ayscough, 
2005). The importance becomes evident by disruptions of these connections as seen in 
muscular dystrophies such as Duchenne- or Becker’s muscular dystrophy, which cause 
muscle weakness and to an increasing degree degeneration of myofibres (Carmignac and 
Durbeej, 2012).
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The giant protein titin
Titin, formerly known as connectin, is the largest known polypeptide. Although it is not 
a filamentous structure, it connects thin- to thick filaments, and is therefore regarded as 
the third filament system of the muscle. This giant protein contains around 30 000 amino 
acids and has a molecular weight of 3-3.7 MDa.  Due to the presence of its isoforms, 
there exist a variety in weight and length of titin (Maruyama, 1977). Titin localises 
in parallel to the thin and thick filament and covers half of the sarcomere length from 
Z-line to M-band. It contains several interaction sites to sarcomeric proteins, such as 
actin, myosin and MyBP-C. The N-terminal end of titin is fixed to the thin filament at the 
Z-line through alpha-actinin, whereas the C-terminus of titin binds to the thick filament 
as well as to myomesin and thereby anchors at the M-band (Labeit, 1997). The A-band 
region of titin consists mainly of repetitive immunglobulinlike (Ig) and fibronectin-typIII 
(Fn3) domains. The I-band region, on the other hand, shows Ig-domains, which is termed 
“PEVK-segment” that consists of prolin (P), glutamate (E), valin (V) and lysine (K). In 
this region, variations are found, which influence the muscle elasticity. In addition to 
the PEVK segment, a second domain exists in the I-band part of titin, which modulates 
muscle elasticity called the “N2-region”. In this region, there exist three alternative 
spliced forms: N2A, N2B and N2AB. The N2B variant is regarded as the stiffest form 
of all three isoforms and, together with N2AB, it is exclusively expressed in the heart 
(Voelkel and Linke, 2011). The combination of these domains lead to the function as a 
molecular spring that defines the sarcomeric stiffness, and thereby regulates passive force 
through flexible extension of the described domains (Linke, 1996;  Linke, 2000). 
The C-terminal region of titin, which is localised parallel to the A-band, consists mainly 
of fibronectin typ III (Fn3)-repeats and Ig-domains (Labeit, 1992), which interact with 
myosin and MyBP-C (Freiburg and Gautel, 1996). It was proposed that integration and 
localisation of these proteins are regulated through titin (Gregorio, 1999).  Moreover, 
multiple protein binding sites are known at the C-terminus of titin, which localises in the 
M-band. In this region, oppositely directed titin molecules overlap to each other to form a 
dimer (Obermann 1996). Through the direct binding to the structural protein myomesin, 
this dimerised structure is stabilised. At the M-band region additional binding sites exist 
for Calpain 3 (Kinbara, 1997), FHL2 (Lange, 2002), Nbr1 (Neighbor of Brca gene) and 
p62 (sequestom1) and MURF (muscle-upregulated RING finger protein) (Gregorio, 1999). 
MURFs were shown to regulate transcriptional processes, and thereby act as important 
trigger for signal transduction (Arya, 2004;  Lange, 2005). Thus, it is speculated that the 
cellular processes involving titin are regulated not only at the protein level but also at 
the gene level. Furthermore, Murf1 binds to titin at the highly evolutionary conserved 
kinase domain (Gautel, 1995). This kinase domain is positioned at the periphery of the 
M-band, and its structure is similar to myosin light chain kinase (MLCK). The classical 
MLCKs phosphorylate the regulatory myosin light chains at the head domain and thereby 
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myosin orientation (Kamm and Stull, 2001). However, the function at the C-terminal 
end by the titin kinase is currently not well understood. Detailed in vitro experiments 
revealed that titin kinase phosphorylates the protein telethonin (TCAP), which is located 
at the Z-band and crucial for sarcomere assembly (Zhang, 2009) The interaction of these 
proteins, which are positioned in two different regions of the sarcomere, indicated that 
titin kinase and TCAP are in close proximity, which may occur during reorganization of 
the cytoskeleton (Mayans, 1998).This suggests a function during sarcomere assembly.
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3.1.2 Sarcomere assembly
The sarcomere assembly describes the process in which the thin- and the thick filament 
systems are combined to form sarcomeres, which than built up the myofibril. Actin- and 
myosin filament, titin and many of their associated proteins were intensively investigated. 
Several mouse models have underlined their importance for muscle function, and human 
diseases could be linked to specific mutations in sarcomeric proteins. Still, the process 
how these structures are formed initially is rather unknown. Evidence for an evolutional 
conservation is given by the highly consistent shape of the sarcomere of approximately 
2µm length and 1µm in diameter. Regardless the size of an organism, the size of the 
sarcomere and its structures stays constant among species, ranging from Drosophila and 
zebrafish to human (Page and Huxley, 1963;  Brenner, 2010).
Over the past years, several models have been proposed to explain the sequence of events 
that lead to a fully functional myofibre. The current understanding is mainly based on in 
vitro studies, which describe the formation of the initial structures in the cell periphery. 
Stress-fibre like structures (Schmidt and Hall, 1998) or small units of actin filaments 
with premature Z-bands (I-Z-I bodies) were observed as the first organised structures 
that are regarded as the premyofibrils (Rhee, 1994;  Sanger and Sanger, 2008). These 
actin-containing structures accumulate and connect to the plasma membrane most likely 
through integrin adhesion sites (Pardo, 1983;  Sparrow and Schock, 2009). 
As illustrated in Figure 3, the cytoskeletal actins accumulate and integrate α-actinin at 
the overlapping N-termini, which form a premature Z-band. The fusion of α-actinin was 
observed in living cells by fluorescent labelled protein (McKenna, 1986) and show a 
first diffuse plain distribution which then organises to small regular lines. Observation 
in chicken myotubes confirmed this localisation and suggested dynamic regulations 
during the alignment of myofibrils (Dabiri, 1997). During the assembly capping proteins, 
like N-RAP and Tmod are bound to the terminal ends of premyofibrils to regulate the 
length and stability of filamentous actin (Gokhin and Fowler, 2011). Additionally, non-
muscle myosins (NMM) integrate in the central region of the thin filament. How NMM 
incorporates in this structure is not clear, but in vitro study have shown that phosphorylation 
in their tail regions regulate the motility of this myosins, which effected the early filament 
assembly (Sabry, 1997). At this stage of the sarcomere assembly, an alternating pattern 
is visible, which is caused by the NMM and the premature Z-bands. titin associates with 
Z-band proteins and align in a stepwise fashion along the filament (Ehler and Gautel, 
2008). This formation of titin is thought to regulated the spacing between actin- and 
myosin filaments (Whiting, 1989). The binding to the N-termini of actin in the early phase 
of the assembly, suggested that titin establishes the formation of the sarcomere. Various 
knockout experiments and transgenic models support an essential role of titin during 
sarcomere assembly (Person, 2000;  van der Ven, 2000). In these models impairment of 
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the thick filament organisation was prominent, which supported the evidence that titin 
adjust the spacing between Z-bands and regulate the incorporation of myosin filaments 
and proposed that myosin filaments assemble timely after the formation of the initial 
cytoskeletal scaffold (Rhee, 1994). However, it remains unclear how titin aligns before 
its C-terminus can bind to the M-band. First when the NMM are exchanged by muscle 
class II myosins the final composition of the sarcomere is completed. To these myosins, 
M-band proteins i.e. myomesin integrate and build the M-band; the C-terminal part of 
titin associates. However, the role of the M-band for sarcomere assembly is not finally 
clarified. As the M-band serves as anchor for the C-terminal titin, which modulate muscle 
elasticity, it may counteract force imbalances and improve stability (Agarkova, 2003). 
This completes the scaffold and results in the mature sarcomere. 
Apart from the sequential integration of sarcomeric proteins, contraction seems to be 
crucial for the uniform arrangement. It was an interesting finding that muscle cells assemble 
and develop better after electric pulse stimulation, which stimulated contractility (Fujita, 
2007). Further, it was shown in cardiomyocyte cultures, inhibition of the contraction by 
different chemicals leads to disorganisation of the sarcomeres. As soon as the reagents 
were removed, the sarcomeres recover and show normal assembly (Simpson, 1993). 
premyofibril
mature myofibril
actin
non-muscle myosin
myosin
α-actinin
titin
Z-bodies
Figure 3: Modell of the sarcomere assembly. The assembly of sarcomere starts at the periphery of the 
muscle cell, where cytoskeletal actins accumulates and form the premyofibril. Actin-binding proteins and 
non-muscle myosin integrates in the forming filament. The premature Z-line (Z-bodies) is formed with titin 
binding at the N-terminus. Capping proteins regulate the length of the aligning actin filaments and muscle 
myosins exchange the non-muscle myosins. Additional proteins are incorporated and form the Z-line and 
the M-band, respectively. By contraction the structure linearize and forms the final sarcomere (modified 
from Sparrow and Schock, 2009) 
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Table 1: Number of uncharacterised 
genes. The number of protein-coding 
genes for each organism (human, 
mouse, rat, chicken and zebrafish) is 
shown, followed by their publication 
record (modified from NCBI database). 
Publications that described more than 100 
genes were excluded for this calculation 
(updated march 2012).
endurance performance. On the contrary, the fast twitch (type II) fibres have -in general- a 
higher glycolytic capacity. They utilize oxidative as well as anaerobic metabolisms for 
energy production (Dubowitz and Pearse, 1960). These fibres display a higher maximal 
shortening velocity and are faster fatigable (e.g. Musculus extensor digitorum longus).
To add even more complexity, different fibre types vary in their gene isoform composition. 
It is reported for MHC that each isoform show slightly different rates of cross-bridge 
cycling, with results for example in a different shortening velocity (Bottinelli, 2001). This 
may be explained by variations in size of the MHC lever arm, which allows larger shifts 
during the contraction process (Warshaw, 2000). Further, the troponin subunit C (TnC) 
exists in different isoforms, which vary in their Ca2+ sensitivity (Veigel, 1999). Due to 
the importance of the different cellular processes involved, it seems likely that additional 
genes exist to regulate or modify muscle function.
3.2 Screening for novel striated muscle genes 
As explained in the previous section, the force production involves several diverse 
processes; and it forms a very complex network. Since the current knowledge about 
how such network forms is rather limited, further understanding through annotating 
of novel genes might shed a light on elucidating the detailed processes and linking the 
Organism Numberof genes
Without
publication
Human 20272 3233 (15.9 %)
Mouse 28766 12148 (42.2 %)
Rat 27506 18526 (67.4 %)
Chicken 17309 14156 (81.8 %)
Zebrafish 32032 23869 (74.5 %)
interactions among the different cellular processes. The existence of unknown factors 
becomes obvious by the calculated number of the “uncharacterised genes” shown in 
Table 1. Although the protein-coding sequences are known, the functional annotations 
of a large number of genes across species are still missing. In human, a comparatively 
small number of protein-coding genes have no publication (15.9 % of total genes). In 
comparison, the percentages of uncharacterized genes to the total number of genes are 
much higher in model organisms:  42.2 %, 67.4 %, 81.8 % and 74.5 % in mouse, rat, 
chicken and zebrafish, respectively. Such a high number of uncharacterised genes is 
surprising as years of extensive usages of high-throughput methods (e.g. microarrays, 
serial analysis of gene expression (SAGE), deep sequencing) have generated large lists of 
genes; however, there is a very little progress on giving functions to such identified genes. 
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gene annotation was a motivation behind to combine available databases and screen for 
these unknown genes to identify new components of the striated musculature. 
3.2.1 Databases and their yield of in silico data
To screen for uncharacterized genes, the following databases and data sets were utilized. 
UniGene (http://www.ncbi.nlm.nih.gov/unigene) (Wheeler, 2003) is a database of non-
redundant sets of transcript sequences. Each entry is classified under the same transcription 
locus (gene or expressed pseudogene). By filtering these records for a specific tissue 
results in a set of genes, genes with a preferential expression for a certain tissue (e.g. 
heart) were identified. With the assumption that evolutionary conserved genes are likely 
to have an important function, the filtered genes of different organisms were combined 
using the HomoloGene database (http://www.ncbi.nlm.nih.gov/homologene) as a source 
of information about homologs.  In order to filter for uncharacterised genes, literature 
Figure 4: Scheme of database organisation. The combination of publically available databases for gene 
selection, literature information and expression studies allows to search for conserved, tissue-enriched as 
well as uncharacterised genes. MeSH (medical subject headings); SAGE (serial analysis of gene expression); 
EAA (exon array analysis).
information provided by the PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/) 
was integrated. When a gene is characterised, results are usually published in scientific 
journals. Using this common practice as a basis for measurements, a gene with only one 
or no publication is regarded as “uncharacterised”. To make more educational filtering, 
an additional information was obtained through the Medical Subject Headings (MeSH) 
(http://www.ncbi.nlm.nih.gov/mesh) vocabulary system to index articles for a specific 
expression studies
gene selection
UniGene HomoloGene
literature information
PubMed MeSH
SAGE Microarray EAA
conserved, tissue-enriched 
and uncharacterised genes
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topic, or here the target tissue. The systematic combination of these databases yields 
in screening for uncharacterised, evolutionary-conserved genes with tissue-enriched 
expression (Uchida, 2009). To add further information, data from high-throughput studies 
were integrated to obtain an overview of the expression patterns of uncharacterised genes. 
The following datasets were utilized:  SAGE, microarrays and expression data from exon 
array analysis (EAA) that identified tissue-enriched alternative splicing isoforms (Gellert, 
2009;  Gellert, 2011).
Through this highly organized screening procedure (Gellert, 2010), a number of novel 
genes were identified. The next challenging step was the initial characterisation of these 
candidates. In order to test whether these candidates have an important functional impact, 
an appropriate model system is required.
3.2.2 Zebrafish as model system for muscle research
The zebrafish (Danio rerio) serves as a model organism in this study. This tropical 
freshwater fish belongs to the minnow family (Cyprinidae) and has become a widely 
used model organism in developmental biology and molecular genetics over the last 
years. The genome of the zebrafish is sequenced (www.sanger.ac.uk/Projects/D_rerio/) 
and shows evolutional conservation to humans, especially regarding the early vertebrate 
development. For example, the keysteps in the heart development, from the migration 
of precardiac cells to the looping process and the chamber differentiation, exist in equal 
measure in human, mouse and zebrafish (Stainier, 1993). Moreover, the developmental 
processes are very rapid compared to the mouse (Mus musclulus). Further, physiological 
processes in zebrafish and human are remarkably similar and may be even better for 
comparison than that of mouse, due to the fact that the murine heart beats around 7 to 10 
times faster than the human heart (Dahme, 2009), whereas those of zebrafish are more 
similar to those of human (Arnaout, 2007; Chan, 2009).
The zebrafish as a model organism offers a number of advantages, such as the transparency 
of the eggs that allows simple access for imaging, and the possibility of live monitoring 
of the developing organs. Furthermore, an efficient breeding results in hundreds of eggs 
per mating to superb number of specimens compared to any other model organisms. 
Furthermore, the external development of the embryo offers an easy access for genetic 
manipulation in vivo. One possibility for gene manipulation to analyse the function of a 
specific gene is to block its expression and investigate the thereby formed loss-of-function 
phenotype. To achieve this functional assay, gene specific oligonucleotides that bind to the 
complementary strand of the mRNA target gene can be used. When such oligonucleotides 
are present in the cell, ribosomes cannot bind for translation, which leads to specific 
inhibition of the target protein. For the usage of this antisense technology, Morpholino-
phosphoroamidate antisense oligonucleaotides (MOs) are widely used in the zebrafish 
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research (Nasevicius and Ekker, 2000).  These synthetic molecules copy the RNA structure 
and contain a morpholine ring instead of a ribose ring that binds the specific bases for the 
target gene. These morpholine rings are connected through phosphoroamidate, instead 
of phosphate as in the case of RNAs, which is not negatively charged and therefore, 
less prone to non-specific interactions with other cellular components (Stirchak, 1989; 
Heasman, 2002). This organisation allows for a standard base pairing. Furthermore, this 
construction is not recognised by the enzyme RNase H, an endonuclease that cleaves 
RNA, and thus MOs are very stable structures (J.E. Summerton, 2007). By the design of 
the specific target sequence, MOs can either interfere with translation or splicing of the 
target mRNAs; thereby gene expression is inhibited. For zebrafish manipulations, MOs 
are injected once at an early developmental stage, which this causes the dilution of the 
MO concentration during the growth of the embryo; this leads to transient knockdown of 
the gene. 
As in any other transient loss of function assays, the specificity and the off-target effects 
through the injection of this artificial substance exist (Eisen and Smith, 2008).  Thus, 
careful controls for these experiments are necessary. Taken all the above facts together, 
this technique offers an versatile way to block gene expression for loss-of-function studies. 
For this reason, the zebrafish animal model was used in this study to rapidly assess whether 
the predicted candidate genes play an important role in the muscle development or not.
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3.3 Aim of the study
The striated musculature requires a tight cooperation of diverse processes to regulate 
its main function, which is the muscle contraction. The assembly of actin- and myosin 
filament form the basis of the sarcomere, which acts as smallest contractile unit of the 
striated muscle tissue. Their filament assembly, a controlled elongation and precise 
alignment within the sarcomeres as well as the connection to another and to the plasma 
membrane are essential for muscle function. The different processes depend on each other 
and need to be discussed in context rather than focusing on single aspects. However, the 
knowledge regarding these essential processes and their potential crosstalk is relatively 
limited. 
One possibility to elucidate the lack of these connections is that further, still unknown 
factors are involved.  In order to understand potential interactions between these involved 
processes requires the functional analysis of novel genes. Through a highly organized 
screening procedure a number of new genes were identified, which are foreseen to be 
evolutionary conserved and expressed in striated muscle tissue (Uchida, Jenniches 2009; 
Gellert, Jenniches 2010). These genes might be involved in muscle specific processes and 
their functional annotation might shed some light on the complex field of muscle function.
The primary aim of this study was the initial characterisation of one of these genes, 
namely LRRC39.  Further aims of this work were:
•	 To evaluate its expression patterns and to define the subcellular localisations
•	 To investigate its functional importance by loss of function studies in zebrafish
•	 To determine its interaction partner and analyse its influence on muscle function.
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4 MATERIAL AND METHODS
4.1 Molecular biology methods
4.1.1 Reverse transcriptase PCR (RT-PCR)
For the expression analysis in adult mouse tissue, RNA was isolated from fifteen different 
mouse organs:  brain, eyes, lung, heart, liver, kidney, spleen stomach, small intestine, 
colon, white adipose tissue (WAT), brown adipose tissue (BAT), testis and uterus. The 
preparation of the tissues was done according to the Current Protocols in Molecular 
Biology: Tissue Collection for Systematic Phenotyping in the Mouse. The samples were 
collected, washed in ice-cold PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mMNa2HPO4-2H2O, 
1.4 mM KH2PO4) and snap frozen in liquid nitrogen. The homogenisation of a tissue 
was conducted using Polytron in the presence of TRIzol reagent (Life Technologies, 
Darmstadt). After purification of RNA by following the protocol of TRIzol reagent, 
two µg of the purified RNA were reverse transcribed using SuperScriptII First-Strand 
Synthesis System (Life Technologies, Darmstadt) to synthesise the cDNA according to 
manufacturer’s protocol. First-strand cDNA was diluted 1:5 in ddH2O. All reactions were 
carried out in 20 µl volume including:
2 µl Taq polymerase buffer (10x)
1 µl  50 mM MgCl2
1 µl  dNTPs (10 mM)
1 µl  primer mix (10 µM)
0.2 µl  Taq polymerase (Eppendorf)
1 µg cDNA template 
The following PCR reaction condition was used:  
Step   Temperature  Time
Initial denaturing 95 °C   2 min
Denaturing  94 °C   30 sec
Annealing  58-62 °C  30 sec     x cycles
Extension  72 °C   1 min
Final extension 72 °C   7 min
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The amplified PCR products were separated in 2% agarose gel, diluted in TE-buffer (10 mM 
Tris-HCl, 1 mM EDTA, pH 8.0), containing ethidiumbromide and were visualised under 
UV light. The band size of the products was controlled by standard marker (GeneRulerTM 
DNA Ladder Mix, Fermentas). Specific primers for murine Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and beta-actin were used to standardise RT-PCR experiments. 
For expression analysis in zebrafish (Tübinger strain), total RNA from different 
developmental stages were collected: 12 hours after fertilisation until day seven. The 
RNA was prepared using TRIzol Reagent and transcript to cDNA using SuperScriptII 
First-Strand Synthesis System as described above.
The DNA sequences for all used genes are accessible via Ensembl database (http://
ensembl.org). For sequence analysis, the SeqBuilder software from DNASTAR lasergene 
8 was used. For the designing of primers, Primer3 (http://frodo.wi.mit.edu/) was utilized. 
All primer sequences were tested for their specificities using BLAST (http://blast.ncbi.
nlm.nih.gov/Blast.cgi) or BLAT for zebrafish sequences. 
gene forward primer reverse primer product size 
mLrrc39 E3/4 
GGAAGACTCTCCCTTCTTCT 
E6/7 
CTTCGCATTCTGTCTAGTGA 
454 bp 
mLrrc39 E3/4 
GGAAGACTCTCCCTTCTTCT 
E7/8 
CCTCAGATTCGTCATTTCTT 
599 bp 
mGAPDH E 5 
ACCACAGTCCATGCCATCAC 
E 5 
CATGCCAGTGAGCTTCCCGT 
168 bp 
mβ-actin E 4 
CAACGAGCGGTTCCGATG 
E 4/5 
GCCACAGGATTCCATACCCA 
67 bp 
zLrrc39 E3/4 
GTGGAAGACTCTTCCTCCAG 
E7 
CTCAAAACTAGCGTGTCCAG 
546 bp 
zGAPDH E4/5 
CTTCCTTCCTGGGTATGGAA 
E5 
CAATGCCAGGGTACATGGT 
120 bp 
zβ-actin E3/4 
GAGCACCAGGTTGTGTCCAC 
E4/5 
CTCATTGTCATACCATGTGAC
CAG 
138 bp 
Table 2: RT-PCR primers. This table lists the primers used for RT-PCR analysis. Targeted genes are shown 
in the first column. The primer name, which is given according to the target exon (E) or exon junction, is 
shown together with the sequence for forward and reverse primers, respectively. The last column shows the 
expected PCR-product size for the corresponding primer set.
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4.1.2 Generation of tagged fusion proteins
The fusion proteins are constructed for the expression analysis in cells. They allow 
observation of the subcellular localisation without immunostaining. Therefore the 
sequence for Lrrc39 and Myh1 (forward primer: GCAGAGGAGCGATGCGAC; reverse 
primer: GAGCTCAGATTTTTCCTGCTCAATTTG; product size: 1920 bp) were amplified by 
PCR and cloned into pGEM®-T Easy Vector System (Promega, Catalog #A1360). The 
verified sequence was subcloned in th following three vectors: 
1. pEGFP-C1 (Clontech, Catalog # PT3028-5), which contains a N-terminal coupled 
eGFP 
2. pEGFP-N3 (Clontech, Catalog #PT3054-5), which contains eGFP at the C-terminal 
end of the target protein 
3. pcDNA™3.1/V5-His A (Life Technologies, Catalog # V810-20) containing 
C-terminal V5 epitope and polyhistidine tag
The insert was enzymatically cut by BamH1 and Sal1, and ligated into the Bgl2 and 
Sal1sites of pEGFP-C1 and –N3. The insert for pcDNA 3.1/V5-His was prepared using 
BamHI and Sal1, the vector with BamH1 and Xho1, respectively.  Insert and final vector 
were ligated with T4-DNA-Ligase (Promega) over night at 16 °C. For the transformation 
of the DNA in electro-competent cells (XLblue), GenePulserTM (Bio-Rad) was 
used. Cells were resuspended in 200 µl LB-medium (Lennox, ROTH) and plated on 
appropriate LB-antibiotic plates and incubated at 37 °C overnight. The bacterial cells 
carrying the transformed plasmid were antibiotic resistant and grew as single colonies, 
which were picked and inoculated in LB-medium at 37 °C and shaking at 210 rpm. Cells 
were harvested on the following day and the plasmid was extracted using NucleoSpin® 
Plasmid kit (Macherey-Nagel). 
The construct was tested by transfection into HEK293T cells, followed by Western Bot 
analysis (described in section 2.3.3). To cite the pEGFP-N3 vector as an example see 
Figure 2, the transfection efficiency was tested in HEK293T cells and the corresponding 
protein lysate was analysed by immunoblotting with antibodies against the enclosed tag, 
here GFP. Additionally, the specificity of the commercially available antibody for Lrrc39 
was tested with this approach. 
4.1.3 Yeast-two hybrid
The full sequence of the murine Lrrc39 was amplified using the primer Lrrc39BsmB1 
(5’CGTATTTCGTCTCCCATGACAGAAAGTGCGGTTTGTACC3’) and Lrrc39Sal1 
(5’ CGATACGTCGACTTATTACATTTTTCTGACCTCTGGTGG3’). The PCR were 
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carried out under following condition using Phusion Polymerase (Finnzymes) to reduce 
the mutation rate:
 10 µl   Phusion buffer (5x)
 1 µl   dNTP mix (10 mM)
 2.5 µl   Primer Mix (10 µM)
1 µg   Template cDNA
  0.5 µl  Phusion Polymerase (Finnzymes)
35 µl   ddH2O
Total volume 50 µl
Following amplification conditions were chosen:
Step   Temperature  Time
Denaturation  98 °C  30 sec
Denaturation  98 °C  30 sec
Annealing  55 °C  50 sec      40 cycles
Extension  72 °C   30 sec
Extension  72 °C   7 min
Storage   4 °C    
After amplification, the PCR reaction mix was separated in a 1 % agarose gel, containing 
0.1 % ethidiumbromide for visualisation under UV light. The according band was isolated 
and purified using PCR clean-up Gel extraction Kit (Macherey-Nagel). To insert the PCR 
product into pGBKT7 vector (Clonetech), in the Y2H vector it was enzymatically digested 
with BsmBI (NEB) for 2 h at 55 °C followed by Sal1 digestion for 2 h at 37 °C. The produced 
insert with a size of 1014 bp was separated by gel electrophoresis and purified. The DNA 
was precipitated by Phenol/Chloroform/Isoamylalcohol. The DNA concentration was 
measured using spectrophotometer Nanodrop (PEQLAB Biotechnologie GmbH). Before 
ligation of the insert into the final vector at 16 °C overnight, the pGBKT7 vector was 
prepared using the restriction enzymes NcoI and SalI (both from NEB). The ligation 
reaction was transformed into XLblue by electroporation and plated on appropriate LB-
antibiotic plates and incubated at 37°C overnight. The colonies were picked and inoculated 
as described before. The plasmid DNA was extracted using NucleoSpin® Plasmid kit 
(Macherey-Nagel). The final product was sequenced, verified and used as bait protein 
for the Y2H screen. The Matchmarker Two-Hybrid System 3(Clonetech) that was used 
contains the bait protein, which is fused to a GAL4 DNA-binding domain (DNA-BD) and 
the preys, which consist of a library of cDNA that is fused to the GAL4 activation domain 
(AD). When the bait protein, here Lrrc39 binds a specific library fusion protein, the two 
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fused domain are in close proximity and thereby activate the transcription of reporter 
genes. The interacting clones from the library were isolated and sequenced. Obvious false 
positive candidates, like non-coding parts of the cDNA were removed as well as non-
specific preys. For Yeast two hybrid screening, the construct was sent for service to the 
DKFZ, Heidelberg.
4.1.4 Whole mount in-situ hybridisation
In-situ hybridisation is a method to visualise a specific RNA sequence in the entire tissue 
by labelled complementary RNA strands (probes). For this study it was used to analyse 
the expression pattern of Lrrc39 in murine embryonic tissues. For sample preparation, 
pregnant wildtype mice were sacrificed at the corresponding day after vaginal plug. The 
whole mount mouse embryos at the developmental stage E10.5 and E11.5 were dissected 
of the uterus tissue and fixed in 4 % PFA at 4 °C overnight. After washing in ice-cold 
PBS for 30 min the samples were dehydrated through methanol series of 25 %, 50 %, 75 
% and twice in 100 % at room temperature for 10 min each. The antisense RNA probes 
were generated and labelled with digoxigenin-UTP (Roche) by SP6 RNA polymerase 
(Promega). The detailed hybridisation procedure is described in (Wilkinson, 1992) and 
was done accordingly. Embryos were post-fixed in 4 % PFA and imaged using Leica 
M205 FA.
4.1.5 Gene expression profiling
The zebrafish embryos at 3 dpf were selected by phenotype and pooled in batches of 
fifteen individuals each. The following four different conditions were used: 1. without 
injection; 2. Standard control MO injection; 3. zLrrc39 MO targeting the ATG site and 4. 
Control MO targeting the ATG site of a specific gene on a different chromosome.
All embryos were taken from the same zebrafish mating. The RNA was extracted from 
pooled, snap frozen samples and homogenised in 500 µl TRIZOL reagent (Life technologies, 
Darmstadt) and incubated for 5 min at room temperature. The gene expression profiling 
using GeneChip Zebrafish Genome Array (Affymetrix) was performed. The complete 
zebrafish cDNA was hybridized to the Affymetrix GeneChip following the manufacturer’s 
protocol. The pre-processing of the data, including background subtraction was performed 
according to the robust multi-array average (RNA) procedure.
4.1.6 In-vitro transcription
For zebrafish mRNA microinjection experiments, the full length messenger RNA of 
murine and zebrafish Lrrc39 were cloned in pGEM-4Z vector (Promega) using following 
primers:
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mlrrc39_forward:  5’-AAAAGATCTACCATGATGACAGAAAGTGCGGTT-3’
mlrrc39_reverse:  5’-AAAACTAGTTCAATTACTTTCTCCATCAGAATG-3’
zlrrc39_forward:  5’-AAAGATATCACCATGACGGGGGTCACGGTG-3’
zlrrc39_reverse:  5’- AAAGATATCCTATGCCGTTTCTGACACACC-3’
The plasmid DNA was linearized using Sal1 digestion at 37 °C for 2 hours. The mRNA 
synthesis was performed using the Ambion mMESSAGE mMACHINE Kit (Ambion 
AM1340) according to the manufacture’s protocol. The synthesised mRNA concentration 
was determined photometrically and diluted to 2µg/µl in RNase free water.
4.2 Cell biological methods
4.2.1 Morpholino oligonucleotide microinjection
The following Morpholino antisense oligonucleotide (MO) were designed as described in 
(J. Summerton and Weller, 1997) and purchased from GeneTools (www.gene-tools.com): 
MO lrrc39ATG1:   5’-ATGATGATACGGAGCCGCAAATTTC-3’
MO lrrc39ATG2:  5’-CGCAAATTTCACTTCACACTCACAT-3’
MO lrrc39Spl1:    5’-TGCACGTACCTACCCACTGCTCTTC-3’
MO standard CTRL:  5’-CCTCTTACCTCAGTTACAATTTATA -3’
The lrrc39 RNA sequence was targeted at the start codon to block the entire translation 
with MOlrrc39ATG1-2, and within the sequence by MOlrrc39 Spl and 2. All MO stocks 
were diluted in ddH2O to 1mM. For all experiments, the optimal MO concentration 
was tested in three different concentration (high: 500 µM MO; medium: 200 µM MO; 
low: 100 µM MO). Zebrafish embryos were microinjected with a volume of 2nl of MO 
during one-cell-stage. Needles were pulled from glass capillary tubes using a flaming 
micropipette puller (Model P-97, Sutter Instruments Co.) and injections were performed 
using a microinjector. To control the injection procedure all MOs were diluted in phenol 
red (Sigma) for visualisation. A minimum of fifty eggs were used for each injection. In 
order to control the injection technique and the MO specificity, the following controls 
were used: Phenol Red without any MO; a standard control MO, directed against the 
human β-globin pre-mRNA (GeneTools) and MO targeting a specific non-related gene.
The capped mRNA of lrrc39 was prepared as described in section 2.1.6 and was injected 
at the one to two cell stage. For rescue experiments co-injection of 200 mg/µl mRNA and 
200 µM MOlrrc39ATG1 were performed.
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4.2.2 Electron microscopy
Transmission electron microscopy (TEM) uses a high voltage electron beam to examine 
a sample at a very fine scale.  In order to analyse the fine structure of the sarcomere in 
zebrafish, the larvae were anaesthetised with Tricaine (Sigma; A5040) at 5 dpf, treated 
with 100 mM CdCl2 for equal contraction (Baker, 1944)  and fixed in 3 % Glutaraldehyde 
in cacodylate buffer (21.4 g Na-cacodylate, 75 g sucrose/ liter) at 4 °C overnight.  The 
sample preparation for transmission electron microscopy (TEM) was done essentially as 
described before (Rieger and Koster, 2007). The zebrafish larvae were washed twice for 
10min each in sodium cacodylate buffer and incubated in 1% osmium tetroxide in veronal 
acetate buffer (14.7 g Na-Veronal; 9,7 g Na-acetate/500 ml) with 4% sucrose for 2 h at 4 °C. 
The samples were dehydrated in a gradient ethanol series (20, 30, 50, 70, 90 and 100 % for 
15 min each). Ethanol was removed and exchanged by propyleneoxide (PO) and incubated 
for 30 min, followed by gradient exchange to Epon (4 g Epon, 3 g DDSA (Dodecenyl 
Succinic Anhydride), 1 g NMA (Methyl-5-Norbornene-2,3-Dicarboxylic Anhydride), 0.1 
g DMP (2,2-dimethorypropane) per 10 ml). The Epon blocks polymerised at 60 °C for 
24 hours before ultrathin sections of 70 nm were prepared using an ultramicrotome and 
mounted on grids. The sections were contrasted with uranyl acetate and analysed with a 
Philips CM10 TEM, operated at 100 kV. The tail skeletal muscle of two MOcontrol-injected- 
and two MOLrrc39-injected zebrafish larvae were examined. 
4.2.3 Cell culture methods
C2C12 and HEK293T cell lines were grown in DMEM (1 g/ml Glucose) media (GIBCO®), 
supplemented with 10 % FCS and 100U/ml penicillin, 100 µg/ml streptomycin and 300 
µg/ml L-glutamine. Before transfection, cells were grown for 2-3 days at 37 °C and 5 % 
CO2. One day prior transfection, cells were trypsinized (0.05 % trypsin, 0.02 % EDTA in 
1x PBS) and plated at 20-30 % confluence. For transfection of each 10 cm culture dish, 
0.5 ml 2xHBS (280 mM NaCl; 1.5 mM Na2HPO4-7H2O; 50 mM HEPES; pH 7.0), were 
gently mixed with 10 µg DNA, 61 µl 2M Ca2Cl2 in 0.5 ml ddH2O. This transfection mixture 
was immediately transferred to the cells by drop wise distribution. Cells were incubated 
at 37 °C and 5 % CO2 for 24 hours. After media change the cells were maintained for 
further 24 hours. Additionally, cells were treated with 0.2 µM Jasplakinolide (ALX-350-
275) for 1 h, or with 2 µM Lantrunculin A (ALX-350-130) for 30 min (both reagents from 
Enzo life sciences GmbH). Cells were washed in PBS and used for stainings or Western 
blot analysis. 
For radiolabelling, which was used to document the incorporation of phosphate and 
thereby analyse changes in phosphorylation patterns in combination or absence of Lrrc39, 
HEK293T cells were re-suspended in 4 ml DMEM media, supplemented with 10 % FCS 
and 10 µl [γ-32P] dATP (100 µCi)  and incubated for 2 hours at 37 °C. 
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After immunoprecipitation of the transfected proteins and SDS gel electrophoresis the 
nitrocellulose membrane was documented by phosphoimager.
4.2.4 Isolation, cultivation and transfection of neonatal rat cardiomyocytes
Primary neonatal rat cardiomyocytes (NRC) were freshly isolated and plated on fibronectin 
(10 µl/ml) coated culture slides in Medium 199, containing 10 % horse serum, 1 % 
Penicillin-Streptamycin-Glutamine (Invitrogen), Ara C and AmphotericinB, and were 
incubated at 37 °C. On the second day after isolation, cells were transfected with full 
length mLrrc39 in pEGFP-C1, pEGFP-N3 and His/V5 using transfection reagent ESCORT 
III (Sigma, L3037). The transfection procedure was done according to manufacturer’s 
protocols. The transfected cardiomyocytes were cultured for another two days in Medium 
199 (2 % FCS, 1 % Penicillin-Streptamycin-Glutamine (Invitrogen) before fixing in 4 % 
PFA followed by antibody staining etc. Lrrc39 expression was analysed by GFP signal 
on a fluorescent microscope (Zeiss Imager.Z1, Carl Zeiss MicroImaging, Inc.) using 40x 
or 100x objective. Micrographs were analysed using AxioVision Release 4.5 and ImageJ 
software.
4.2.5 Isolation, cultivation and transfection of primary chicken cardiomyocytes
Fertilized Chicken eggs were purchase from a local farm (Geflügelzucht Körner, Usingen). 
The fertilized eggs were incubated at 38 °C until sample preparation at day 11. After 
cleaning of the eggs with 70 % EtOH, the embryos were decapitated and the hearts were 
isolated and collected in a 10 cm preparation dish containing DMEM media. The primary 
explants were mechanically disaggregated and transferred to 50 ml falcons. The finely 
chopped tissues were additionally enzymatically disaggregated by 0.25 % trypsin for 
15 min at 37 °C. The supernatant were discarded and the pellet was suspended in 0.15% 
collagenase, diluted in PBS and incubated for 30 min at 37 °C. The supernatant was 
collected in 10 cm culture dish. The collagenase digestion was repeated twice and the 
collected supernatant incubated for 30 min at 37 °C. The pre-plating step is necessary to 
minimise fibroblast contamination in the final culture. Due to their faster adherence, these 
cells were attached to the culture dish while the cardiomyocytes were still floating in the 
media. After final incubation, the supernatant was used for transfection.
The full-length mLrrc39-eGFP fusion protein as well as the empty vector (described 
in section 2.1.2) was used for electroporation with Amaxa® Rat Cardiomyocyte –
Neonatal Nucleofector® Kit (Lonza, Cologne) according to the manufacturers’ protocol. 
Transfected cells were cultured for 24 h in DMEM containing 10 % horse serum and 1 % 
Penicillin-Streptamycin-Glutamine (Invitrogen) before analysis. 
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4.3 Immunhistochemistry
4.3.1 Vibratome sections 
The utilised transgenic zebrafish lines contain a fluorophore, which was analysed 
by confocal microscopy. Due to the thickness of the whole zebrafish, tissue sections 
were prepared using a vibrating microtome. Therefore, dechorinated zebrafish were 
anaesthetised with Tricaine (3-amino benzoic acidethylester, A-5040, Sigma) and fixed in 
4 % PFA overnight at 4 °C. After washing in PBS, the samples were orientate in 4 % low 
melting agarose (Sigma) and left for harden in a wet chamber for at least six hours at 4 °C. 
The in agarose fixed samples were glued to the section base and cut in 50 µm thick slices 
with a in solution vibrating knife using Microtom VT 1000S (Leica). The transparent 
slices were transferred to objective slides and embedded in Mowiol. Images were taken 
using confocal microscopy (Leica TCS SP2 AOBS).
4.3.2 Immunostaining
The immunhistological experiments oblige the exact localisation of relevant molecules 
within the cells. Therefore the cultivated cells are fixed for 10 min at room temperature 
in 4% paraformaldehyde (PFA), which forms crossbridges of aminogroups and 
thereby stabilises the subcellular structures. After washing steps to remove the PFA, 
the samples were permeabilised with 0.05 % Triton-X100 for 5 min. This detergence 
increases permeability of the cell membranes and erleichtert antibodies to enter the cell. 
After permeabilisation and washing steps with PBS (137 mM NaCl, 2.7 mM KCl, 4.3 
mMNa2HPO4-2H2O, 1.4 mM KH2PO4), unspecific binding of antibodies were minimised 
by 0.1 % BSA (bovine serum albumin) treatment for 10 min. By this saturation of free 
binding sites background staining is reduced. Next step is the incubation of the primary 
antibody against the target protein. The antibodies were diluted in PBS as listed in Table 
3. The incubation time depended on the quality of the antibody as well as the sample 
and was generally done at 4 °C overnight. After PBS washing steps, the incubation of 
the secondary antibody that was directly coupled to a fluorophore followed. In order to 
identify the cell shape additional fluorophore-labelled substances were used. To visualise 
structure proteins, the peptide Phalloidin (Phalloidin-TRITC, Sigma) was used, which 
binds F-actin (Cooper, 1987). For nuclear staining of the cells DAPI (4’,6’-diamidino-2-
phenylindol) was added. After staining and final washing steps the cells were embedded in 
Mowiol® (Calbiochem) and visualised using different microscopes. For each secondary 
antibody a negative control was used, with the same conditions but excluding the primary 
antibody in order to recognise unspecific binding. 
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The whole mount immunofluorescence staining for zebrafish followed the same 
principle. The dechorinated fish were collected into 24-well plates. The E3 medium 
was removed and the samples were washed once with PBS. Samples were fixed in 4 % 
PFA overnight at 4 °C.  Zebrafish were washed in PBS and permeabilised for two hours 
at room temperature in PBS, containing 1 % Triton X-100 (Roche, Karlsruhe) and 0.1 
% DMSO.  Primary antibody were diluted in PBS as shown in Table 3 and incubated 
overnight at 4 °C following by washing steps and nuclear staining with DAPI (1:1000; 
Invitrogen). Samples were mounted on objective slides in mowiol and visualised using 
a Leica confocal microscope TCS SP2 AOBS with argon and helium-neon lasers and 
63xlens. Images were processed with Leica imaging software and ImageJ.
For oil red O stainings, the fixed larvae were incubated in 60 % 2-propanol for 30 min, 
followed by 0.5 % oil red O (sigma) in 60 % 2-propanol. 
Name Dilution Source, (order ID) 
Lrrc39 1:50 Abnova ( H00127495-B01P) 
mMaC Myomesin B4 1:100 Developmental Studies Hybridoma Bank 
Titin M8 1:50 Gift from Prof.M.Gautel 
GFP 1:500 Abcam (ab6556) 
α-actinin 1:200 Sigma (clone EA53) 
F59 1:20 Developmental Studies Hybridoma Bank 
MyBP-C 1:200 Gift from Prof.M.Gautel 
 
 
 
Goat-anti-rabbit-Alexa 488 1:1000 Invitrogen (A11008) 
Goat-anti-mouse-Alexa 594 1:1000 Invitrogen (A11005) 
Donkey anti-mouse Cy5 1:200 Millipore (AP192S) 
Table 3: Antibodies for immunofluorescence staining. Utilised primary and secondary antibodies are 
listed by antibody name, dilution, company and order number.
4.3.3 SDS gel electrophoresis and immunoblot analysis
To identify specific polypeptides within a complex protein mixture, SDS-PAGE (sodium 
dodecyl sulphate- polyacrylamide gel electrophoresis) and western blot were applied. 
This technique was used for the identification of proteins after immunprecipitation 
to verify potential interaction partners. The snap frozen tissues were homogenized in 
Extraction-buffer ( 100 mM Tris-HCl, 12.7 mM EDTA, 10 % SDS, pH 8.0) supplemented 
with Protease-Inhibitor-Cocktail-Tablets (1tablet/ 10 ml; Roche) using ultrasonic device 
(Sonoplus, Bandelin Electronic, Berlin).
To have equal amounts of samples per lane the protein concentration were measured by 
DC Protein Assay from BioRad based on the Lowry method. In alkali solution (reagent 
A) proteins form complexes with copper-II-ions, this is known as biuret-reaction that 
leads to the blue colouring of the sample. The so formed protein complex reacts with 
folin-ciocaltheau-phenol-reagent (reagent B) that enhances colour change and increases 
the sensitivity of the assay.  The colour intensity is proportional to the amount of proteins 
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and can be measured by photometry at 750 nm (Fluorimeter FLUOstar Galaxy, Bio-Rad). 
The samples are diluted in Extraction buffer and Laemmli buffer (66.7 mM Tris-HCl, 0.2 
% SDS, 27 % Glycerin, pH8.0) to a final concentration of 2 µg/µl. 
The denaturated polyacrylamide gelelectophoresis (PAGE) after Laemmli (Laemmli, 
1970) allows the separation of a complex protein mixture by the size of the polypeptides. 
Based on the application of sodiumdodecylsulfate (SDS), which binds amino acids and 
charges them negatively, the proteins can be separated in an electric field. Due to the 
correlation of molecule mass and electrophoretic mobility are separated by size. To reduce 
potential disulfide bonds of proteins strong reducing agents like dithiotreitol (DTT) were 
used. For protein separation, gradient Bis-Tris gels (NuPage 4-12 %, Life Technologies) 
were utilised. The electrophoresis was performed at 175 volts in semi-dry modules (Xcell 
SureLockTM Mini-Cell, Invitrogen) in MES-SDS running buffer. A prestained protein 
ladder (Novex®Sharp Pre-stained Standard, Invitrogen) was applied to estimate the 
band size. After electrophoresis, proteins were transferred to nitrocellulose-membrane 
(Amersham Bioscience) at 30 V for 2 h in Transfer-buffer (25 mM Bicine, 25 mM Bis-Tris, 
0.1 mM EDTA, 20 % Methanol). In order to control the protein transfer, membranes were 
stained with RedAlertTM (Novagen) prior to Western Blot analysis. For immunodetection 
the membrane was saturated with 5 % milk pulver in TBST (137 mM NaCl, 20 mM 
Tris-HCl, 0.1 % Tween) for 1 h and incubated with specific primary antibodies (listed 
in Table 3) overnight at 4 °C. After washing steps in TBST, the secondary antibody 
was incubated for 1 h at room temperature; followed by washing steps. The membrane 
bound proteins were visualised by chemiluminescence via horseradishperoxidase (HRP)-
coupled secondary antibodies and Supersignal West Pico Chemiluninescent Substrate 
(Pierce) and were detected by VersaDoc MP5000 (Bio-Rad).
Table 4: Antibodies for Western Blotting. Utilised primary and horse radish peroxidase (HRP)-conjugated 
secondary antibodies are listed by antibody name, dilution, company and order number.
Antibody Dilution Source, (order ID) 
Lrrc39 1:1000 Abnova (H00127495-B01P) 
Myomesin 1:1000 Developmental Studies Hybridoma Bank 
Anti-GFP 1:10 000 Abcam (ab6556) 
Anti-V5 1:5000 Novex®, Life technologies  
MF20 1:1000 Developmental Studies Hybridoma Bank 
Goat anti-mouse-HRP 1:1000 Pierce (1858413) 
Goat ant-rabbit-HRP 1:1000 Pierce (1858415) 
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4.4 Biochemical methods
4.4.1 Immunoprecipitation 
For in vitro analysis of Lrrc39 and its binding to myosin heavy chain immunoprecipitations 
were performed. Cultured chicken cells were transfected as mentioned in section 2.2.4. The 
utilised constructs are described in section 2.1.2. After harvest of the cells and preparation 
in lysis buffer (150 mM NaCl, 1% Triton® X-100 in 50 mM Tis-HCl, pH 8.0), the samples 
containing the epitope-tagged fusion protein were processed using µMACS GFP Isolation 
Kit (#130-091-125, Milteny Biotec) to isolate the specific protein of interest with their 
binding partners. Therefore, cells were incubated with anti-GFP microbeads and isolated 
by column. The samples were eluted in pre-heated buffer, containing 1 % SDS, 1 mM 
EDTA 50 mM DTT in 50 mM Tris-HCl (pH 6.8) and additionally for gel loading 10 % 
glycerol and bromphenol blue to visualise the sample.  Afterwards, the samples were 
processed for Western Blot analysis as described in the previous section and the results 
were visualised in VersaDoc MP 5000 System (BioRad).
4.4.2 Mass spectrometric analysis of zebrafish tissue
Mass spectrometry identifies proteins by ionisation of chemical compounds to charge 
peptides and measurement of their mass-to charge ratio.  This technique was utilised 
for proteome analyse of zebrafish samples. Therefore, the zebrafish tails were freshly 
isolated at 120 hpf to provide the aged matched condition to the electron microscopy 
experiments. For each sample to be read by mass spectrometry, twenty individual tails of 
zebrafish larvae were dissected using forceps and directly snap frozen in liquid nitrogen. 
The samples for MOLrrc39 and a standard MO control zebrafish (MOCtrl) were pooled. Three 
replicates were prepared for each experiment. 
To be able to precisely quantify the changes of protein expression, the stable isotope 
labelling (SILAC) approach was used for this study. This technique applies 13C6-Lysine 
(Lys-6) labelled bacteria, yeast or mouse cells to label whole zebrafishes, which represent 
the internal protein standard for protein quantification. Proteins of the heavy standard 
were mixed in one-to-one proportion with the control- and MOLrrc39 group, respectively. 
A comparison of the ratios between samples and the heavy labelled fish allows precise 
quantification of protein expression. Protein samples were typsin digested and measured 
by LC-MS/MS. The pre-processing of the data, including background subtraction, 
elimination of contaminants and normalisation was performed using MaxQuant (maxquant.
org) software (Cox, 2009). For final data analysis Microsoft Excel was utilised. Results 
were expressed as means. A two tailed t-test was performed to assess differences between 
the two groups. P-values < 0.05 were considered as significant.
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4.4.3 Structural analysis by homology modelling 
Visualisation of 3D structures requires NMR or crystallographic analysis, which was not 
available for LRRC39. To test the validity of the results and to visualise the binding of 
this protein, its three dimensional structure was predicted based on homology modelling. 
Assuming that, a similar primary structure is likely to form a similar conformation the 
protein internalin-A (PDB entry: 2omxA) that shows highly similar sequence patterns 
(Wollert, 2007) was chosen as template. For molecular visualisation the software PyMOL 
version 1.3r1 (pymol.org) was utilised. The structure information for α-helical myosin 
heavy chain (PDB entry: 3DTP) was taken from (Alamo, 2008).
4.5 Animal procedures
Adult Tübingen strain zebrafish (Danio rerio) and transgenic lines Tg(myl7::eGFP-
HsHRAS)s883 (D’Amico, 2007), Tg(aactin::eGFP ) (Higashijima, 1997) were maintained 
in system water at 28.5 °C according to standard methods (Westerfield, 1993). Embryos 
were taken from natural mated adult fish and raised in embryo media E3 (5 mM NaCl, 0,17 
mM KCl, 0,33 mM CaCl2, 0,33 mM MgSO4). For analysis embryos were anesthetized 
with Tricaine (ethyl 3-aminobenzoate methanesulfonate , Sigma) before preparation.
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5 RESULTS
The analysis of novel genes in the striated musculature started with a computer-based 
comparison of different databases in order to filter genes by their expressions and identify 
genes that are specific or enriched in heart- and/or skeletal muscle and are not published 
in the target field of research (Uchida, Jenniches, 2009;  Gellert, Jenniches 2010). The 
identified genes were further selected by their known family members or their protein 
domains. This work focuses on one of such candidate genes termed leucine rich repeat 
containing 39 (Lrrc39), which is highly conserved through different species. 
In the first part of this section, the expression pattern of this gene was analysed in different 
tissues, in order to verify the in silico screen. Furthermore, the subcellular localisation of 
Lrrc39 was examined (Chapter 5.1).
The second part concentrates on the functional importance of Lrrc39 in vivo, including the 
phenotypic description after gene knock-down and detailed morphological analysis using 
immunhistological stainings, confocal microscopy as well as gene and protein analysis by 
microarray and mass spectrometry, respectively (Chapter 5.2). 
The third part of this section focuses on the interaction to other proteins by analysing the 
binding partner of Lrrc39. Furthermore, the effect of this interaction was investigated in 
vitro, using freshly isolated neonatal myocytes.
5.1 Expression pattern
5.1.1 Sequence and expression of LRRC39 are highly conserved
LRRC39 is an evolutionary-conserved gene, which encodes the protein of 334 to 342 amino 
acids. Apart from a comparable short N-terminal and C-terminal region, the sequence of 
LRRC39 shows a repetitive pattern of leucine-rich repeat (LRR) domains. This sequence 
is highly conserved across species ranging from human to zebrafish as shown in Figure 
5A. The homologs of LRRC39 were documented in seven different organisms from 
zebrafish to human, based on the results of HomoloGene database (www.ncbi.nlm.nih.
gov/ homologene). To obtain the sequence similarity scores, ClustalW2 (www.ebi.ac.uk/
Tools/ msa/clustalw2) was utilised. 
The human LRRC39 (Homo sapiens: NP_653221.1) encodes 335 amino acids in length, 
which consists predominantly of LRR-domains. These conserved LRR-domains appear 
always in the central region of the sequence across species; however, it is slightly longer 
in human compared to all other species. The sequence length of LRRC39 in Canis lupus 
is identical to the human form, but less LRR domains are detected. The homologs in Bos 
Taurus and Rattus norvegicus are one amino acid less than that of human, whereas those 
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A
B
335aa
Homo sapiens
NP_653221.1
Mus musculus
NP_780622.1
334aa
335aa
337aa
343aa
334aa
Danio rerio
NP_001017760.1
342aa
Canis lupus
XP_547262.1
Gallus gallus
XP_422312.2
Rattus norvegicus
NP_001103107.1
Bos taurus
NP_001069893.1
Pairwise Alignment Protein DNA
H.sapiens vs. M.musculus 85,9 86,0
H.sapiens vs. R.norvegicus 85,6 84,9
H.sapiens vs. G.gallus 69,0 71,7
H.sapiens vs. D.rerio 63,9 64,1
M.musculus vs. R.norvegicus 94,9 94,1
M.musculus vs. G.gallus 67,9 67,7
M.musculus vs. D.rerio 61,8 62,1
Identity (%)
R.norvegicus vs. G.gallus 66,5 66,7
R.norvegicus vs. D.rerio 62,1 62,7
G.gallus vs. D.rerio 60,3 61,4
LRR
LRR
LRR
LRR
LRR
LRR
LRR
Figure 5: Sequence alignment of 
LRRC39. A: Conservation of Lrrc39 
protein sequence in different species NCBI 
reference sequence numbers are stated 
(modified from HomoloGene database 
entry). Centrally located leucine-rich 
repeat domains (LRR) exist in all shown 
sequences. B: Pairwise alignment scores 
among selected organisms indicate high 
sequence identity on protein as well as on 
DNA level.
of chicken (Gallus gallus), zebrafish (Danio rerio) and mouse (Mus musculus) are longer 
(342 aa, 343 aa and 337 aa, respectively). In mice, an isoform of 175 aa is present, which 
contains only three LRR-domains and is alternative spliced after the fifth exon.
The pairwise alignment of the human sequence and model organisms that were used in 
this study are shown in Figure 5B. Sequence identities, analysed by ClustaW ranging 
from 60 to 86 %. The highest similarity is between mouse and rat with 94.1 % identity 
at the level of DNA sequence and a slightly higher identity of the protein sequence with 
94.9 %.  The human sequence compared to those of mouse and rat yields in 85 to 86 % 
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identity. The weakest compliance shows the comparison between chicken and zebrafish 
with the identity of 60.3 %. However, the distribution of the LRR domains stays highly 
similar. Taken together, the alignments of the different LRRC39 homologs indicate high 
conservation across species.
5.1.2 Expression of LRRC39 in heart and skeletal muscle
To verify the analysed database entries for the LRRC39 expression, RT-PCR experiment 
using fifteen different adult murine tissues was conducted. As shown in Figure 6A, a 
clear expression of the murine Lrrc39 in heart and skeletal muscle tissues was recorded, 
which verify the predicted pattern based on our in silico results. Apart from the adult 
striated muscle tissues, the expression of Lrrc39 was detected in the eyes and in the brown 
adipose tissue (BAT), whereas the white adipose tissue (WAT) shows no expression. In 
addition, a smaller band was observed in BAT to indicate the presence of an isoform as 
mentioned in the previous section. 
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Figure 6: Expression pattern of Lrrc39 in murine tissues. A: RT-PCR of adult mouse tissues. In adult 
mouse tissues, Lrrc39 is expressed in eyes, heart, brown adipose tissue (BAT) and skeletal muscle (28 
cycles of RT-PCR reaction). The murine Gapdh served as an internal control, and ddH2O was used as a 
negative control. Whole mount in situ hybridization of mouse embryos at developmental stage E10.5 (B) 
and E11.5 (C). A clear expression of Lrrc39 in heart and somites can be observed. 
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To further characterise the expression pattern of Lrrc39, whole mount in situ hybridisation 
experiment was performed using murine embryos. For this experiment, two different 
embryonic stages were analysed: 10.5 days after fertilisation (E10.5) and 11.5 days 
after fertilisation (E11.5), which are shown in Figure 6B and C, respectively. In both 
developmental stages,  Lrrc39 transcripts were detected in the developing heart as well 
as in the somites, which will form the skeletal muscle tissue in later time point of the 
development. In addition, a strong Lrrc39 expression was detected in the ventricle of the 
heart. The expression in the somites seems to be restricted to the myotome at E10.5 and 
increased in size at E11.5. Additionally, Lrrc39 transcripts are detectable in the fore limb. 
Some weak signals were detected in the eye and neck region. As it is clearly visible from 
the above figure, high expression of Lrrc39 in the developing heart and somites to further 
confirm the results of our in silico screening.
As it was shown in Figure 5, LRRC39 is conserved from lower species, including 
zebrafish. To verify its evolutional conservation, RT-PCR experiment was conducted 
using zebrafish tissues. For this purpose, total RNA of zebrafish larvae was collected at 
different developmental stages:  from one hour post fertilisation (hpf) to seven days post 
fertilisation (dpf). Unlike mice, which can be inbred to establish genetic homogeneity, 
zebrafish are generally outbred (Monson and Sadler, 2010), and therefore, genetic 
variations are higher. To circumvent this problem, all samples mentioned above were 
taken from one Tübingen-strain mating. The reason behind choosing Tübingen over 
other strains is that the sequencing project of zebrafish was conducted with this strain 
(http://www.sanger.ac.uk/Projects /D_rerio/). By using this strain, in principle, it would 
be possible to base the understanding on the publicly-available sequences, which can be 
obtained from major public databases, such as ENSEMBL and Entrez Gene databases. 
As shown in Figure 7A, RT-PCR analysis in zebrafish larvae resulted in detection of 
lrrc39 expressions starting relatively weak at the first day of  development and increased 
to a plateau phase from  two to four days post fertilisation, followed by a slight decrease 
from day five onwards. During these early developmental stages of the zebrafish, the 
organs are too small to gain enough material for a more detailed, tissue-specific analysis. 
Thus, although it is informative, RT-PCR experiment can only indicate the presence of 
lrrc39 during the development of zebrafish larvae. As it has been done for mouse (Figure 
6), whole-mount in situ hybridisation should provide spatial information of lrrc39. 
Conveniently, such datasets are available from high-throughput analysis by Thisse and 
Thisse (Thisse, 2004), which are accessible through the ZFIN organisation (www.zfin.
org). These results are shown in Figure 7B and C. Lrrc39 transcripts were detected in the 
somites and pectoral fin muscles, however no clear signal could be found in the heart at 
this early developmental stage. As shown in the above results, the expression patterns of 
lrrc39 are similar to its mouse homolog. 
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Figure 7: Expression pattern of lrrc39 in zebrafish tissues. A: RT-PCR of zebrafish 
tissues showing lrrc39 transcripts arising at 12 hours post fertilisation (hpf), increasing 
to a plateau phase from two to four dpf followed by a slight decrease from five to seven 
days post fertilisation (dpf) (40 cycles of RT-PCR reaction). The zebrafish GAPDH 
served as an internal control, and ddH2O was used as a negative control.  Whole 
mount in situ hybridization of lrrc39 from lateral view (B) and dorsal view (C) taken 
from (Thisse, et al., 2004).
5.1.3 Characteristic localisation of LRRC39 in the sarcomere
The above results are informative about the expressions of LRRC39 transcripts. Since 
proteins are the ones doing the job of muscle maintenance, the expressions of LRRC39 
were analysed at the protein level using fusion proteins and an antibody against LRRC39. 
First, in order to obtain subcellular localisation of LRRC39, GFP-fused Lrrc39 was over-
expressed in various cell lines. As shown in Figure 8A, the fusion protein of Lrrc39 was 
localised in the cytoplasm of a cell as well as predominantly at the edges of the cell. 
The constructed fusion proteins are co-localised with structural protein F-actin, which is 
visualised by phalloidin staining. Next, in order to test the specificity of a commercially 
available LRRC39 antibody (Abnova), co-localisation with different Lrrc39-fusion 
proteins over-expressed in various cell lines (HEK293T, NIH-3T3, P19CL6 and C2C12 
cells) was performed, which confirmed its specificity. The specificity of anti-LRRC39 
antibody was further tested by Western Blot experiment using over-expressed fusion 
proteins in the same set of cells (data not shown). 
Since Lrrc39 was localised in similar patterns like F-actin, its properties for actin 
polymerization and depolymerization were tested (Figure 8B). Cultured C2C12 cells were 
treated with 0.2µM Jasplakinolide (Enzo life sciences GmbH), a reagent that promotes 
actin polymerisation (Holzinger, 2009), and on the contrary LatrunculinA (2µM; 
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Alexis®Biochemicals), which promotes actin depolymerisation (Chesarone, 2009). 
Lrrc39-eGFP fusion proteins were detected in cytoplasmic localisation of the all observed 
cells. DMSO treated cells served as control. In Jasplakinolide-treated cells, a clear increase 
in cell size was observed. Furthermore, Lrrc39 expression was increased compared to the 
control cells. The harsh conditions after the Latrunculin A treatment lead to reduced cell 
number and cell size, which is visualised by DIC images. Surprisingly, Lrrc39-tranfected 
cells were viable. In fact, all surviving cells were GFP-positive to indicate some functional 
roles of Lrrc39 for actin polymerization and depolymerization.
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Figure 8: Localisation study in 
different cell lines. A: Localisation 
of Lrrc39-fusion proteins in NIH-
3T3, p19Cl6 and C2C12 cell line 
were detected at the cell periphery, 
co-localised with F-actin (stained 
by phalloidin). B: Documentation of 
actin dynamics results in increased 
expression of Lrrc39 after actin 
polymerization (Jasplakinolide) 
and dense localisation after actin 
depolymerization (Lantrunculin 
A) DMSO as solvent was used for 
control. DIC: differential interference 
contrast microscopy; nuclear staining 
by DAPI in blue.
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Although co-staining with the cellular actin filaments was shown above, the utilised cell 
lines do not (or only weakly under certain culture conditions as in the case of C2C12 
cells) contain the typical sarcomeric structure of the musculature. Therefore, primary 
cardiomyocytes were used for immunostainings. Unlike the above used cultivated cells, in 
freshly isolated murine adult cardiomyocytes, a regular, striated pattern of the expression 
of Lrrc39 was observed (Figure 9). Identical expression patterns were obtained in the 
primary isolated neonatal rat cardiomyocytes. To define the region within this distinctive 
sarcomeric structure, antibodies of widely used markers were used for co-staining. An 
antibody against α-actinin that is exclusively expressed in a dense region along the Z-line 
of the sarcomere was used (Figure 9A and B), which resulted in no co-localisation. In 
contrast, the co-staining with an antibody against myomesin, which localises at the centre 
30 µm
10 µm
30 µm
Lrrc39 α-actinin merge
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B
C
Figure 9: Subcellular localisation in cardiomyocytes. Endogenous Lrrc39 visualised by antibody 
staining in freshly isolated neonatal (A) and adult cardiomyocytes (B and C). Lrrc39 is expressed in 
a regular, striated pattern and is co-localised with the M-band marker myomesin (C). Lrrc39 (green), 
a-actinin and myomesin (red); DAPI (blue).
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of the sarcomere, showed the overlapped staining pattern (Figure 9C). As described in 
Chapter 1.1.2, the composition and the function of this region are not fully understood. 
Therefore, the unique staining pattern of Lrrc39 indicates the possibility as a novel 
member of sarcomeric proteins. 
5.2 Phenotypic description and morphological analysis 
As shown in the above sections, the expression patterns of Lrrc39 in the heart and 
skeletal muscle as well as a specific localisation within the sarcomeric structure were 
observed. In order to investigate a potential function of Lrrc39 in these tissues, the 
expression level was altered in vivo. For this purpose, zebrafish larvae were utilized as 
a model organism. In order to conduct a loss-of-function experiment, microinjections of 
morpholino oligonucleotides (MO) were performed to reduce the protein level of Lrrc39. 
On the contrary, an injection of capped mRNA of Lrrc39 to increase its protein level was 
performed to provide a gain-of-function experiment. 
For the loss-of-function experiment, two independent MOs were used to target the start 
codon of lrrc39. Furthermore, third MO was utilized to provide mis-splicing of lrrc39 to 
provide an additional mode of knockdown. As describe in section 2.2.1, three different 
concentrations of each MO were employed. At the highest concentration of 500 µM many 
embryos developed severe body edema as well as a high lethality rate was observed. At 
medium concentration (200 µM), the zebrafish developed cardiac edema and was viable 
during the sample period. Further, no stiking body edema or severe mutations as seen in 
the high concentration were detected. Low concentration of 100 µM developed relatively 
normal and no obvious phenotype was observed. To control the phenotype, age-matched 
larvae from the same mating without any injection and with injections of a standard MO 
at the same concentration were used.
The effects of these different MOs result in the same reproducible phenotype. To provide 
detailed phenotypic analysis, different zebrafish strains and transgenic reporter lines 
were utilized as follows. As a wild type strain, Tübingen was used. The transgenic line 
Tg(myl7::eGFP-HRAS)s, which is driven by the myosin light chain 7 promoter, was 
employed to label cardiac cells. In this strain, the fusion of the GFP tag to the membrane- 
bound ras protein allows an easy observation of the shape and the orientation of cardiac 
cells. Furthermore, transgenic line, Tg(acta::eGFP) was utilized to label skeletal muscle 
cells through GFP expression under the control of the alpha actin promoter. In the 
following subsections, the detailed phenotypic analyses using the above techniques and 
strains are provided.
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5.2.1 Loss of LRRC39 leads to alterations of the ultrastructure
The loss-of-function of lrrc39 in the zebrafish larvae showed phenotypic changes that 
are evident from 3 dpf on as shown in Figure 10. The controls develop normally and no 
differences in the eye, jaw, tail or cardiac development could be detected. Compared to 
the control injected embryos, the inhibition of lrrc39 led to a slight reduction in the body 
size; the eyes appeared smaller; and the lower jaw was deformed. A reduced swimming 
activity was observed, and the larvae developed pericardiac edema, which is a sign of 
abnormal heart function. As embryos developed, the deformation in the tail was observed 
as well as the enlargement of pericardiac edema became evident. These results show that 
the functions of Lrrc39 are required for the proper development of zebrafish larvae.
In order to confirm the importance of Lrrc39 during the development of zebrafish, a 
gain-of-function experiment was performed. Although one would expect somewhat of 
the opposite effects than the loss-of-function experiment. However, as shown by the over-
expression of GFP-fused Lrrc39 in the previous sections, having more of this molecule 
in the cells than one necessary need might cause impairment in the proper development 
of zebrafish. To test this hypothesis, an overexpression of Lrrc39 in zebrafish larvae by 
mRNA injection was performed. Surprisingly, the gain-of-function resulted in the similar 
phenotype as in the case of the above mentioned loss-of-function experiment. Taken 
above two experiments together, the requirement of Lrrc39 during the development of 
zebrafish is inevitable.
To understand the phenotypes from the above two experiments further, a co-injection 
of lrrc39 MO and mRNA was perform. This approach is used commonly as a rescue of 
the phenotype in the area of zebrafish research (Eisen and Smith, 2008). However, the 
compensation by two extremes (knockdown versus over-expression) did not work. This 
implies that there exists a delicate balance in which the expression level of lrrc39 is 
tightly controlled. In other words, too less or too much of lrrc39 expression leads to the 
deformation in the development of an embryo. 
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Figure 10: General phenotype 
after lrrc39 alteration. A: 
Brightfield images of Tübingen-
strain zebrafish document the 
development at 3 days post 
fertilisation  (dpf) and 5 dpf. First 
row shows non-injected control 
zebrafish and the second row, control zebrafish injected with 
standard morpholino. These control embryos developed 
normally. The third row shows zebrafish after inhibition of 
Lrrc39 by morpholino injection. Reduced body size, smaller 
eyes, deformation in the lower jaw and pericardiac edema 
were observed.  To control non-specific effects in loss-of-
function experiments, age-matched larvea from the same 
mating without any injection and with injection of a standard 
MO at the same concentration were used. B: Knockdown 
efficiency of Lrrc39 was controlled in zebrafish embryos after 3 dpf by Western Blot using Lrrc39 
antibody and the Red Alert (Novagen) stained proteins as loading control. C: Immunofluorescent 
analysis of seletced embryos after 3 dpf showed reduced Lrrc39 staining. D: Gain-of-function 
experiments show larvae after Lrrc39 overexpression using capped mRNA injection, which 
resulted in smaller eyes and pericardiac edema that increased during development. Same controls 
as seen in A have been used. Images were taken with Leica M205 FA.
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Figure 11: Cardiac phenotype after inhibition of lrrc39. The projection of Tg(myl7::eGFP-
HRAS) zebrafish heart images at 48hpf are shown. The reduction of lrrc39 (MOLrrc39) resulted 
in a deformed ventricle (V) whereas the atrium (A) appeared normal. The morphology of 
single cells of the heart were visualised by the expression of eGFP.  MOLrrc39  showed  a 
reduced cell size and disrupted orientation of cardiac cells compared to the control-injected 
sibling (MOCTRL). Leica TCS SP2 AOBS. Scale bar: 50 µm. 
As Lrrc39 expression was detected in the skeletal muscle of the zebrafish, the tails of the 
larvae were investigated. As shown in Figure 12, in the absence of Lrrce39, deformations 
of the skeletal muscle fibres in the tail region were observed. Similar to those of the heart, 
skeletal muscle fibres appeared smaller and disorientated. Confocal imaging of the whole 
zebrafish tail allowed for a detailed morphological analysis. Immunostaining 
Since cardiac edema in zebrafish was observed under various conditions and seems to be 
a rather general phenomenon, detailed phenotypic analysis of the heart was conducted. 
Microinjections in the transgenic zebrafish line Tg(myl7::eGFP-HRAS)  resulted in the 
same phenotype as shown in Figure 10. In order to analyse the heart phenotype in detail, 
vibratome sections of the larvae were prepared, and the GFP signal was visualized using 
confocal microscopy. Figure 11 shows the morphological changes after lrrc39 reduction 
in the heart of two days old larvae. At this developmental stage, the looping of the heart 
took place, the atrioventricular canal (AV-canal) is formed, the two chambers of the 
zebrafish heart are differentiated, and the heart is beating. These early developmental 
processes seem not to be influenced by the loss-of-function of Lrrc39. In the Lrrc39 MO- 
injected zebrafisch (MOLrrc39), the ventricle, which is located in the left part of the image 
(Figure 11), can be clearly distinguished from the thinner atrium, which is visual in the 
bottom right part. However, the surface of the ventricle seems in MOLrrc39. The single 
cardiac cells appear smaller in size and do not orientate in the direction of the AV-canal, 
which is shown in the control heart. 
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Figure 12: Disrupted skeletal muscle of zebrafish embryos after inhibition of 
lrrc39. The zebrafish tail regions were stained with F59 antibody to mark slow muscle 
myosins. MOLrrc39 showed thinner muscle fibres with altered orientation. The myofibres 
appeared curved and showed gaps (arrow) compared to the tightly packed  myofibres of 
the control-injected sibling (MOCTRL).  Images were taken with Leica TCS SP2 AOBS. 
Scale bar: 50 µm.
with F59 antibody were performed to visualise different muscle myosins (Myh1, 2, 4 
and 6). Figure 12 shows an optical section of the longitudinal zebrafish tail at the lateral 
view with the dorsal site to the top. The control injected larvae showed a compact muscle 
layer. Each of the parallel orientated myofibrils spans one somite. At the same anatomical 
position, the MOLrrc39 shows smaller somites but a comparable myofibre length as seen in 
the control. This phenotype is more evident at the macroscopic level as a wavy appearance 
of the muscle fibres was seen. Although the number of fibres per segment is constant, its 
thickness is decreased. As a result, unstained areas are visual between the fibres. 
As disruptions in the heart- and the tail muscle were observed, additional analysis of 
the facial musculature were performed to test whether the absence of Lrrc39 leads to 
disturbance in all striated muscle tissues. The usage of the transgenic line Tg(acta::eGFP) 
allows a continuous observation of the muscle development. In Figure 13, the changes 
between the control and MOLrrc39 injected zebrafish are shown. The images show the 
zebrafish larvae from the ventral side with the head of a larva at the top. The background 
staining in the lower part of the picture marks the yolk sac.  At three days post fertilisation 
(3 dpf), the control larvae had developed the basic muscle fibres of the eyes, the pectoral 
fins and of the jaw area. In contrast to the control, MOLrrc39 showed only weak GFP signals 
and the development of these muscles was not dectecable at this early stage . Two days 
later (5 dpf), a clear α-actin signal was visible at an equally high intensity. Although 
the muscle fibres of the eyes, jaw area and pectoral fins can be distinguished, the fibres 
appeared thinner and partially shorter. In addition, the different localization of muscle 
54
RESULTS
5 
dp
f 
3 
dp
f 
100 µm
CTRLMO Lrrc39MO
Figure 13: Comparison of facial musculature in control and MOLrrc39 zebrafish. 
A: Whole mount images of eGFP expression visualised the facial muscles in 
Tg(acta::eGFP) zebrafish. The micrographs show the zebrafish head from ventral 
views and anterior to the top. The facial muscles of MOLrrc39 were poorly developed 
after 3dpf  in comparison to the control-injected sibling. At 5 dpf, the zebrafish 
head muscles MOLrrc39 were detectable, but the muscle fibres appeared thinner and 
misaligned. Microscope: Leica M205 FA.
fibres was observed in MOLrrc39 injected zebrafish compared to the control. This delayed 
expression of alpha-actin demonstrates an impaired development of facial muscles.
To summarise, the reduction of Lrrc39 in zebrafish larvae leads to wide-ranging 
malformations of the musculature as shown in Figure 9. In general, the muscle fibres 
appear smaller and disorganised, which became evident through careful observational 
studies in the heart (Figure 11), tail muscle (Figure 12) and facial muscle (Figure 13). 
As a conclusion, LRRC39 is a necessary gene for the proper development of the striated 
musculature (both heart and skeletal muscles).
To investigate whether the absence of lrrc39 is accompanied by changes in sarcomere 
architecture, transmission electron microscopy (TEM) was performed.  For this experiment, 
the skeletal muscle of the zebrafish tail was chosen for the higher density of sarcomeres 
within the tissue, which should allow for any structural changes to be detected. As shown 
in Figure14, MOLrrc39 showed massive changes in the sarcomere organisation at 5 dpf. 
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The skeletal muscle of the control larvae (MOCtrl) showed the regular appearance of the 
sarcomere units. The Z-band can be identified by the localisation of T-tubules as well as 
the surrounding, light I-band. In the centre of the darker A-band, the thin, dark M-band 
is visual, surrounded by a narrow light area, the bare zone or H-zone. While the I-band is 
clearly visible in the control, it seems absent in the MOLrrc39. Apart from this, the diameter 
of the myofibres seems irregular and tends to be smaller. Light appearing gaps, surrounding 
the T-tubules, can be observed. Between the single myofibres, an accumulation of fine 
structured material can be detected. Figure 14B shows a single sarcomere of the image 
in detail. The sarcomere length is constant as well as the position of the Z- and M-band 
are persistent. However, the Z-band region was not clearly structured in MOlrrc39, the 
M-band appeared darker and the light area of the bare zone around the M-band was not 
distinguishable. Through the careful analyses at the level of electron microscopy, a striking 
malformation of the sarcomere organisation in the absence of Lrrc39 was observed. 
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Figure 14: Ultrastructural analysis of the sarcomere. Electron microscopic analysis of 
zebrafish skeletal muscle of control-injected (MOCTLR) and Lrrc39 morpholino-injected larvaes 
(MOLrrc39) at 5dpf revealed in disrupted sarcomeric structure. A: Skeletal muscle of MOCTLR 
showed regularly organised sarcomeres with persistent myofibre diameter. In contrast, the fibre 
diameter in MOLrrc39 appeared irregular and gaps around the T-tubules (asterisk) were partially 
filled with fine structured granules (arrow). B: Detailed images show one single sarcomere defined 
by two Z-bands (Z) with the centrally located M-band (M). The two sarcomeres shown were 
consisted in length. The I-band around the Z-band was clearly detectable in MOCTLR, however in 
MOLrrc39 this region were diffuse and the M-band appeared denser. Electron microscopy Philips 
CM10 TEM; scale bare: 1 µm
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5.2.2 Transcriptomics approach based on microarray technology
In order to elucidate the reason behind the disturbed muscle development in MOLrrc39, 
transcriptomics techniques were employed. Microarray experiments allow a global analysis 
of the expression intensity of genes. With this techonology, differential gene expression 
between the two zebrafish samples can be analysed. For the expression analysis, the 
Affimetrix GeneChip Zebrafish Genome Array was used. This chip contains 15,617 probe 
sets, which represent to 14,900 zebrafish specific gene transcripts. For this experiment, 
three zebrafish groups were prepared: (1) Standard MO injected larvae (MOStandard); (2) 
MOLrrc39; and (3) Specific MO injected larvae targeting a different sarcomeric gene as 
an internal control (MOCtrl). Since the earliest visible phenotypes were observed at 3 
dpf, this time point was chosen to profile the above mentioned experimental groups. In 
order to minimise the variation among samples, 15 zebrafish larvae were pooled for each 
condition. Thus, the replication of microarray experiments were omitted. 
Figure 15 shows the distribution of the expression intensities from 15,617 probe set IDs. 
For the further analysis, expression changes higher than two fold of the standard deviation 
were considered. This resulted in the selection of 628 regulated probe sets as documented 
in Figure 15B. Using the complete larvae for the experiment caused a high background 
mainly from eye related genes, which fitted to the observed phenotype (described in 
chapter 3.2.1). By sorting the genes for their Gene Ontology (GO) terms, it was possible 
to filter the results for heart and muscle related candidates. This filter excludes all genes 
without annotated GO terms for further analysis. As shown in Figure 15C, 196 genes, 
which corresponds to 1.26% of the total probe set, were selected. Among them, nine 
genes were differentially expressed with a higher change than two-fold standard deviation. 
These genes are listed in Figure 15D. Among them, two different ATPases were detected, 
which were down regulated. These are a calcium-transporting ATPase (atp2a2) and a 
sodium-potassium ATPase (atpX). Both ATPases are essential for muscle contraction. As 
for the up-regulated genes, five genes were identified. One of them is desmin a, which is 
an intermediate filament of the muscle that connects myofibrils to the sarcolemma and 
investigations in zebrafish reported a crucial role in sarcomere alignment in heart and 
skeletal muscle (Vogel, 2009). Two genes related to myosin folding, Unc-45 and Hsp90, 
were also up-regulated. Unc-45 targets unassembled myosin for proteasome degradation 
(Kim, 2008) and binds to the chaperone Hsp90, which is important for myosin folding. 
Expression of the transcription factor foxn4 was increased. In the zebrafish heart, foxn4 
was shown to regulate the AV-canal formation through the expression of tbx2b (Chi, 
2008). However, the role of foxn4 in skeletal muscle is currently unknown. The second 
transcription factor, which was up-regulated was no tail a, which is a homolog of T, 
brachyury (mouse). This gene contains a conserved T-box DNA binding domain, which 
is known for transcriptional regulation, and has been shown to be important for somite 
patterning in zebrafish (Halpern, 1993). 
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Figure 15: Gene expression analysis by microarray. A: Comparison of gene expression changes 
after Lrrc39 reduction. Microarray analyses were conducted on whole larvae at three days post 
fertilisation. Genes with changes of >2-fold are considered for analysis. B: Distribution of regulated 
genes in the total probe set and C after filtering for Gene Ontology terms heart and/or muscle. D: 
Gene final changes in relation to heart and muscle. 
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Although the intensities of interesting genes might be masked by more abundant genes 
(e.g. eye-related genes), it was possible to describe the phenotypes after loss of lrrc39 to 
a certain extent when appropriate filters were applied to dissect the transcriptomics data 
carefully. Given that only nine genes out of 14,900 zebrafish genes on the array were 
found to be dysregulated might indicate that potential changes in the musculature were 
obscured by using the whole organism for transcriptional profiling. Furthermore, the miner 
regulations might argue for a function of lrrc39 at the level of proteins, instead of RNA, 
through such events as post-transcriptional modifications. In the end, it is not possible to 
give clear indications for major pathways involved and makes it difficult to explain the 
observed phenotype to a full extent. To overcome this problem and with regard to post-
transcriptional regulations, zebrafish muscle of control- and MOlrrc39-injected larvae were 
isolated and prepared for the proteome analysis by mass spectrometry.
5.2.3 Loss of Lrrc39 leads to altered expression of proteins involved in muscle  
 sarcomere assembly
To screen for changes at the protein level, mass spectrometry technology was utilized. 
Since the above mentioned transcriptomics approach based on microarray technology 
indicated the usage of whole organisms results in unsatisfying results, the skeletal muscle 
was chosen to allow for a direct comparison to the electron microscopy results (Figure 14). 
The zebrafish tails were freshly isolated at 120 hpf to provide the age matched condition 
to the electron microscopy experiments. For each sample to be read by mass spectrometry, 
twenty individual tails were pooled for MOLrrc39 and a standard MO control zebrafish. 
Three replicates were prepared for each experiment. To be able to precisely quantify 
the changes of protein expressions, the stable isotope labelling (SILAC) (Westman-
Brinkmalm, 2011) approach was employed. This technique employs 13C6-Lysine (Lys-
6) labelled zebrafishes as internal protein standard for protein quantification. The aged-
matched, “heavy protein samples” from the SILAC-labelled zebrafish were mixed in a 
one-to-one dilution with each of the “light samples” from the experiment (MOCtrl and 
MOLrrc39). A comparison of the ratios between samples and the heavy-labelled fish allows 
precise quantification of protein expressions. The samples were measured using LC-MS/
MS. The pre-processing of the data, including background subtraction, elimination of 
contaminants and normalisation was performed using MaxQuant (maxquant.org) software 
(Cox, 2009).
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Figure 16: Proteome analysis. A: Correlation of experimental zebrafish sample with the SILAC labelled 
control. First row shows three control replicates (MOCtrl), second row the MOLrrc39 replicates. Significant 
changes were marked (green: p<0.05-0.01; yellow: p:0.01 to 0.001; red: >0.001). B: The correlation of the 
replicates to each other showed the reproducibility of the results. C: Volcano-plot illustrates the expression 
intensity of analysed proteins. Results were expressed as means; proteins with p< 0.05 and more than two 
fold change were regarded as significantly changed.
First, the validity of this approach was assessed by inspecting the correlations among 
samples and internal standard as shown in Figure 16A and B. The ratios of heavy to 
light sample materials were plotted against the relative intensity. To visually represent the 
results, significant changes within this groups are marked according to their significance 
level (green: p<0.05-0.01; yellow: p=0.01-0.001; red: <0.001), and unchanged proteins 
are marked in black. The altered proteins represent mainly specific compounds of other 
tissues (e.g. the eyes) and were excluded for the final analysis. The control groups (in 
the upper panel of Figure 16A) show higher correlations than those of MOLrrc39 groups 
(bottom panel in the same figure). Such a trend is expected as morpholino injections result 
in variability in phenotypes, whereas those of heavy-labelled zebrafish are of wild type 
without injections. To further assess the sample quality, the relationship between each 
biological replicate was checked. As shown in Figure 16B, correlations of 0.75 to 0.89 
confirmed the reproducibility of the results. To give a statistical basis of such correlations, 
a two tailed t-test was performed between the two groups (P-values < 0.05).
After quality control and removal of ambiguous protein groups, a total of 3,217 proteins 
was detected Figure 16 C. Among them, 344 proteins were identified to be statistically 
significant in their expressions (p<0.05) between the two groups (MOCtrl versus MOLrrc39). 
Most outstanding was a group of proteins with increased intensity as high as 17.16 to 
50.98 fold (Figure 16C, marked in red). All of these proteins belong to the family of 
vitellogenins (from lat. vitellum, yolk) and were initially described as egg/yolk proteins 
(Serrano-Pinto, 2004).  As the strong increase of these yolk sac proteins differed extremely 
from the rest of the data set distribution, further investigations were needed to control this 
result. Vitellogenins are produced as precursors for lipid- and phosphoproteins, threrefore 
the drastic increase would correlate with the amount of lipoproteins.  To examine whether 
such an increase could be observed, the zebrafish were stained for lipoproteins by Oil-
Red-O, see Figure 17.  
The comparison between MOctrl and MOlrrc39 showed clear difference between the 
staining, which correlated with the size of the yolk sac. Since the prepared tail region 
contained parts of the yolk, changes in lipid- and lipoprotein distribution were likely. This 
control experiment suggests the increase of vitellogenins as consequence of the sample 
preparation and may be due to enlarged yolk sac material. Therefore, vitellogenins were 
excluded from further analysis.
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Figure 17: Distribution of lipoproteins in the zebrafish. Oil-Red-O in control larvae 
(upper panel) shows staining in the yolk. The MOLrrc39 group have comparable bigger 
yolk sacs with correspondingly increased distribution of the dye. The part of the zebrafish 
tails that were utilised for proteome analysis is marked by dashed lines and included parts 
of the yolk sac (arrowhead).
For the further analysis, proteins with more than two fold differences between two groups 
were selected (157 proteins). To grasp an overview about these proteins, the Panther 
database (www.pantherdb.org) was utilized to search for Gene Ontology terms. Since not 
all the proteins have been categorized by the Gene Ontology Consortium (http://www.
geneontology.org/GO.consortiumlist.shtml), 71 out of 157 significant changed proteins 
were identified by the database and clustered by the corresponding GO terms for their 
molecular function as shown in Figure 18. 
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Figure 18: Proteome changes clustered by Gene Ontology terms for their molecular 
function. A: Distribution of regulated genes in the total probe set; B: Gene Ontology descriptions 
for the all significant changed proteins (p<0.05). C: Selection of identified proteins with 
significant changes; sorted by increased fold change. A gene symbol in parenthesis represents 
the gene symbol of a homologous gene.
gene symbol fold change
cacna1s Skeletal muscle L-type calcium channel alpha1S subunit 0.28
(CAPN3) Novel protein similar to vertebrate calpain 3 0.28
(myom2) similar to myomesin 2, partial 0.31
dmd Dystrophin 0.37
nrap NRAP protein 0.44
tmod4 Tropomodulin 4 (Muscle) 0.45
(CACNA2D1)
gene title
Novel protein similar to vertebrate calcium channel, 
alpha 2/delta1
0.49
hsp90a.1 Heat shock protein HSP 90-alpha 1 2.23
hsp90ab1 Heat shock protein 90kDa alpha, class B member 1 2.31
hsc70 Heat shock 70kDa protein 8 2.62
ion channel activity
transporter activity
translation regulator activity
transcription regulator activity
enzyme regulator activity
catalytic activity
receptor activity
structural molecule activity
binding
3217 total probe set ID
119 upregulated
188 unregulated 
(<2 fold change)
37 downregulated
A
B
C
Novel protein similar to human and mouse capping protein 
(Actin filament) muscle Z-line, alpha (CAPZA)
Si:dkey-16k6.1 0.43
hsp10 Heat shock protein 10 (Chaperonin) 3.12
As shown in Figure 18A, the 71 analysed proteins with significant changes were 
grouped in nine GO terms. Of them, 56 proteins were grouped in the GO term “binding” 
(GO:0005488),  38 proteins in “structural molecule activity” (GO:0005198) and 38 
proteins in “catabolic activity” (GO:0003824). The sum of these numbers indicates that 
proteins were clustered in more than one group, which occurred due to multifunctional 
proteins. Several candidates with structural molecule activity are binding to other proteins, 
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therefore an overlap of these groups was observed. However, these data point to that 
MOLrrc39 regulated mainly binding protein, proteins with structural activity and proteins 
with catabolic activity (Figure 18B). Among these regulated candidates a group of actin-
binding proteins were identified, including the following (see Figure 18C): 
•	 Calpain3 (capn3) with decreased expression of 0.28 fold. This protein is located 
in the sarcomeric Z-and M-band and with its protease activity calpain3 cleaves 
cytoskeletal protein  (Taveau, 2003).
•	 Si:dkey-16k6.1, the zebrafish homolog for capz (capping protein muscle Z-line) 
with decreased expression of 0.43 fold. This protein binds actin filaments at barbed 
ends and protects from polymerisation of depolymerisation of actin (Schafer, 
1995).
•	 N-RAP with decreased expression of 0.44 fold. This scaffolding protein is 
expressed in the early phase of myofibril assembly and was reported to bind 
a-actinin and to establish actin polarity (Manisastry09)
•	 Tropomodulin4 (Tmod4) with decreased expression of 0.45 fold, which binds to 
pointed ends of the actin filament and regulates thin filament elongation.
The collective importance of these proteins for initial processes during myofibril assembly 
and their generally decreased expression in MOLrrc39 samples indicated an important 
regulatory function for Lrrc39.
However, by this way of clustering 86 regulated protein entries were excluded, due to 
their missing GO annotation. Manually sorting discovered, apart from the mentioned 
group of vitellogenins, the chaperone hsp90 which are known for role of myosin folding. 
The hsp90a1 and hsp90-ab1 were up regulated by 2.31 and 2.23 fold, respectively. As it 
was described in the introduction, the chaperone hsp90 forms a complex hsp70 and unc-
45. According to this, the expression of hsp70 shows in the absence of Lrrc39 an increase 
of 2.62 fold. For the second protein of this complex no change in protein expression was 
detected. Though, another member of the heat shock family, hsp10 was increased.
Apart from this, the expression of two calcium channels were reduced, which accorded 
with the microarray results. In the context of the phenotypic analysis of the sarcomere, 
which showed changes in the M-band appearance, alterations in corresponding proteins 
were investigated, but no increases were found. Contrary, a protein similar to myomesin 
2 was detected with decreased expression. Furthermore, the protein dystrophin, which 
is known to cause severe muscle damages, was reduced by 0.37 fold change. Taking 
together, proteome analysis of the zebrafish skeletal muscle in the absence on Lrrc39 
resulted in a decrease of actin binding proteins, as well as calcium channels, and in an 
increased expression of heat shock proteins. These results suggest that Lrrc39 interact 
with other sarcomeric proteins.
64
RESULTS
5.3 Molecular mechanism
The proteome analysis of zebrafish muscle after reduction of Lrrc39 uncovered changes 
is a group of proteins, which were categorised by the GO term “binding”. However, 
a mere analysis of protein concentration levels does not allow to distinguish between 
direct and secondary or side effects. In order to understand the mechanism that leads to 
the distortion of the musculature, the next chapter will focus on the direct interactions of 
Lrrc39 to other proteins.
5.3.1 Identification of binding partner by yeast-two-hybrid assay
The characteristic leucine-rich repeat (LRR) domain of Lrrc39 is foreseen for protein-
protein interactions (Bella, 2008) and together with the information from the mass 
spectrometric analysis it was likely that this protein is binding. In order to utilize such 
information, a screening for binding partners of Lrrc39 was performed using yeast-
two hybrid method. The full length mouse Lrrc39 was cloned into the pGBKT7 vector 
(Clontech) and used as bait protein. The yeast-two-hybrid screening was performed at the 
DKFZ, Heidelberg. 
This screen for the murine Lrrc39 resulted in eight interacting proteins, shown in Figure 
19A.  Out of these eight candidates, five belong to the muscle-myosin class II, which 
was introduced in Chapter 1.1. Among them:  the human MYH1 as well as the murine 
homolog Myh1, Myh3, MYH7 and Myh8. The binding of Lrrc39 occurred in all five 
proteins in identical positions between 846 and 1530 aa, shown in Figure 19B. These 
regions correspond to the coiled-coil myosin heavy chain tail domain (also known as 
rod domain), which provides the structural backbone of the thick filament in the muscle 
sarcomere (Zoghbi, et al., 2008). Moreover, the binding region is located in the S2 
fragment of the tail domain, which connects the globular myosin heads and the rod region. 
Apart from the myosin heavy chains, three additional binding partners were detected: 
H19, Rbm25 and a riken clone 2900073G15Rik. The identified 2900073G15Rik gene 
has two homologs in human as well in zebrafish namely myosin light chain 12a and 9, 
regulatory (MLC12 and MLC9). These two genes show sequence identity of 90%, using 
ClustaW for sequence alignment. Although, the screen resulted in additional potential 
binding proteins, the striking group of MHC was further investigated.
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Figure 19: Binding partners of Lrrc39 by Yeast-two-Hybrid screening A: List of binding 
partners from Y2H screen (provided by DKFZ service). The results were subdivided in definite- 
and uncertain interacting proteins and likely false positive and definite false positive interacting 
proteins. Among the first two groups six myosin heavy chain proteins were recognized. B: The 
Lrrc39 binding region (grey box) of the different myosin heavy chains (MYH1, 3, 8, 6 and 7) 
resulted in a similar pattern at the myosin tail region.
N C
0 871 - 1438
N C
854 - 14810
N C
846 - 13070
N C
965 - 14300
N C
947 - 15300
A
B
Prey gene symbol Description
MYH1 myosin, heavy chain 1, skeletal muscle, adult
Myh8 myosin, heavy polypeptide 8, skeletal muscle, perinatal
MYH7 myosin, heavy chain 7, cardiac muscle, beta
Myh1 myosin, heavy polypeptide 1, skeletal muscle, adult
Myh3 myosin, heavy polypeptide 3, skeletal muscle, embryonic
H19 H19 fetal liver mRNA
Rbm25 RNA binding motif protein 25
2900073G15Rik RIKEN cDNA 2900073G15 gene
Uncertain interactors: Preys that that were isolated only once with this bait
COX7A1 cytochrome c oxidase subunit VIIa polypeptide 1 (muscle)
Myh6 myosin, heavy polypeptide 6, cardiac muscle, alpha
Likely false Positives: promiscuous preys
Atp5a1 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha 1
PRDX6 peroxiredoxin 6
RPS20 ribosomal protein S20
COX2 cytochrome c oxidase subunit II
PGM1 phosphoglucomutase 1
COX1 cytochrome c oxidase subunit I
False Positives: fragments from the 3' UTR
SLC31A1 solute carrier family 31 (copper transporters), member 1
Dab2 disabled homolog 2 (Drosophila)
Wdr68 WD repeat domain 68
Interacting Proteins:
MYH 1
MYH 3
MYH 8
MYH 6
MYH 7
1939 aa
1940 aa
1937 aa
1935 aa
1939 aa
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5.3.2 Co-immunoprecipitation experiments confirm an interaction of Lrrc39 with   
 type II myosins 
In order to verify the binding partners from the yeast-two-hybrid screen, 
immunoprecipitations of Lrrc39 were performed. Since the Lrrc39 antibody was not 
suitable for classical immuno-precipitations, the labelled fusion constructs were utilised. 
To exclude any disturbance of the interaction by the tag, different fusion constructs were 
designed and tested as described in Chapter 2.1.2. The full length Lrrc39 as well as the 
potential binding region (939-1579 bp) of Myh1were prepared with N-terminal GFP 
fusion (Lrrc39-eGFP; Myh1-eGFP) and with N-terminal fusion of V5 and 6xHistidine 
(Lrrc39-V5/his; Myh1-V5/his), respectively. To confirm the interaction, freshly isolated 
chicken cardiomyocytes were co-transfected with Lrrc39-eGFP and Myh1-V5/his and 
analysed after GFP pulldown assay. To control the experiment, empty vectors were 
included as negative control.
As shown in Figure 20, after precipitating Lrrc39-eGFP, GFP antibody staining detects a 
Figure 20: Lrrc39-Myosin interaction by immunoprecipitation in primary 
chicken cardiomyocytes. Western Blot analysis after GFP-precipitation of 
co-transfected cells show: 1. GFP antibody staining (Abcam) to control the 
precipitation procedure; 2. The V5-labeled binding partner and 3. Endogenous 
myosin stained  with MF20 (Hybridoma).  After precipitation of Lrrc39-GFP, 
Myh1-V5 was detected (1st lanes). Vice versa, after Myh1-GFP precipitation, 
Lrrc39 is detected by V5 antibody (Novex) staining (2nd lanes). Empty vector 
was used as negative control. Utilised tagged-fusion constructs are shown 
above. 
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strong band of ~66 kDa, which is the expected size of the fusion protein (39 kDa + GFP 
epitope of ~27 kDa). This proves that the experimental setup is working. V5 antibody 
staining detects a strong band with a size of around 75 kDa, a weaker second band below, 
and a third band at ~150 kDa. The prepared Myh1binding region contains 1920 bp, which 
results in a calculated band size of ~71 kDa, plus the fused V5 epitope and the histidine 
tag of ~2.2 kDa. The strongest band at ~75 kDa was slightly above the expected size 
of ~73.2 kDa for Myh1. To prove the binding to myosin, additional antibody staining 
for MF20 (Hybridoma), which recognise muscle myosins was performed. This antibody 
did not recognise the Myh1 fragment at ~75 kDa, but detected a strong band at ~160 
kDa, followed by additional bands between ~180 and ~250 kDa in size. These bands 
with high molecular weight were not detected by V5 antibody. This result confirms the 
interaction between Lrrc39 and Myosin. To control the assay furthermore, the experiment 
was repeated with exchanged fusion tags. Accordingly, Myh1-eGFP was precipitated and 
Lrrc39 was read out by V5 antibody staining (2nd lanes). The GFP staining to control 
the precipitation detected a band at ~100 kDa, which matched the calculated size of 
Myh1-eGFP (99 kDa). The V5 antibody staining detected a ~40 kDa band, which showed 
Lrrc39-eGFP. MF20 staining revealed in two weak bands at ~100 kDa and 150 kDa.
With this approach, the interaction between Lrrc39 and the predicted region on Myh1 was 
confirmed. After precipitation of Lrrc39 and analysis of the eluent, Myh1 was identified 
and vice versa. Furthermore, by utilizing the ability of MF20 to recognize the heavy 
chain of sarcomeric myosins (Gonzalez-Sanchez and Bader, 1984), the binding of Lrrc39 
to various myosin heavy chain proteins, which were identified by Y2H, was confirmed. 
Taken together, the view that Lrrc39 is a novel component of sarcomeres was validated. 
Further experiments in HEK293Tcells entail the same results.
5.3.3 Confirmation of binding by structural modelling
To understand how Lrrc39 interacts with myosins, computational predictions based 
on homology modelling was conducted. This in silico prediction allows for further 
understanding of Lrrc39 as integral part of the sarcomere.
Visualisation of 3D protein structures requires NMR or crystallographic analysis, which 
was not available for LRRC39. To test the validity of the results and to visualise the 
binding of this protein, its three dimensional structure was predicted based on homology 
modelling. Assuming that, a similar primary structure is likely to form a similar 
conformation the protein internalin-A (PDB entry: 2omxA) that shows highly similar 
sequence patterns (Wollert,  2007) was chosen as template. For molecular visualisation 
the software PyMOL version 1.3r1 (pymol.org) was utilised. The predicted 3D structure 
of Lrrc39 forms 12 parallel orientated β-sheets with an arc-like shape. This arrangement 
leads to a concave appearance of the protein and creates a potential binding pocket 
with a diameter of approximately 30 Å. Within this region conserved amino acids are 
straightened towards the core of the binding pocket. These preferentially aromatic amino 
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acids like tryptophan and phenylalanine, which are marked in Figure 21A, are likely to 
play an active role in the binding-process. 
In order to receive an impression about the binding between Lrrc39 and MHC, the two 
protein structure information were modelled in concert. The structure information for 
α-helical myosin heavy chain (PDB entry: 3DTP) was taken from (Alamo, 2008). As 
shown in Figure 21B and C, the model of Lrrc39 shaped exactly around the α-helical 
coiled-coil domain of MHC. This view supported this protein-protein interaction and was 
C
A
B
~30A°
Figure 21: Predicted protein structure of Lrrc39. A:  Ribbon diagram of calculated Lrrc39 protein 
structure viewed from the frontal side, i.e. from the n-terminus on the left to the c-terminus at the 
right side of the image. B: Structural modelling of Lrrc39 and its binding partner MHC (red) from 
lateral view and C from frontal view.
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further suggestive of a regulatory action through the aromatic amino acids in the core of 
the binding region. 
The results of the yeast-two-hybrid screen identified a conspicuously conserved binding 
region on diverse muscle myosins that are illustrated in Figure 19B. This conservation 
suggested a functional role of this region. To examine whether any known characteristics 
Myh1    LEDECSELKKDIDDLELTLAKVEKEKHATENKVKNLTEEMAGLDETIAKLTKEKKALQEA 1009
Myh8    LEDECSELKKDIDDLELTLAKVEKEKHATENKVKNLTEEMAGLDENIAKLTKEKKALQEA 1005
Myh3    LEDECSELKKDIDDLELTLAKVEKEKHATENKVKNLTEELAGLDETIAKLTREKKALQEA 1003
Myh6    LEDECSELKKDIDDLELTLAKVEKEKHATENKVKNLTEEMAGLDEIIAKLTKEKKALQEA 1004
Myh7    LEDECSELKRDIDDLELTLAKVEKEKHATENKVKNLAEEMAGLDEIIVKLTKEKKALQEA 1002
Nmmyh9 MQQNIQELEEQLEEEESARQKLQLEKVTTEAKLKKLEEDQIIMEDQNCKLAKEKKLLEDR 1000
Myh1    HQQTLDDLQAEEDKVNTLTKAKIKLEQQVDDLEGSLEQEKKIRMDLERAKRKLEGDLKLA 1069
Myh8    HQQTLDDLQAEEDKVNTLTKAKTKLEQQVDDLEGSLEQEKKLRMDLERAKRKLEGDLKLA 1065
Myh3    HQQTLDDLQAEEDKVNSLSKLKSKLEQQVDDLESSLEQEKKLRVDLERNKRKLEGDLKLA 1063
Myh6    HQQALDDLQAEEDKVNTLTKSKVKLEQQVDDLEGSLEQEKKVRMDLERAKRKLEGDLKLT 1064
Myh7   HQQALDDLQAEEDKVNTLTKAKVKLEQQVDDLEGSLEQEKKVRMDLERAKRKLEGDLKLT 1062
Nmmyh9  VAEFTTNLMEEEEKSKSLAKLKNKHEAMITDLEERLRREEKQRQELEKTRRKLEGDSTDL 1060
Myh1    QESTMDVENDKQQLDEKLKKKEFEMSNLQSKIEDEQALGMQLQKKIKELQARIEELEEEI 1129
Myh8    QESTMDIENDKQQLDEKLKKKEFEISNLISKIEDEQAVEIQLQKKIKELQARIEELEEEI 1125
Myh3    QESILDLENDKQQLDERLKKKDFEYSQLQSKVEDEQTLSLQLQKKIKELQARIEELEEEI 1123
Myh6    QESIMDLENDKLQLEEKLKKKEFDISQQNSKIEDEQALALQLQKKLKENQARIEELEEEL 1124
Myh7    QESIMDLENDKQQLDERLKKKDFELNALNARIEDEQALGSQLQKKLKELQARIEELEEEL 1122
Nmmyh9  SDQIAELQAQIAELKMQLAKKEEELQAALARVEEEAAQKNMALKKIRELETQISELQEDL 1120
Myh1    EAERASRAKAEKQRSDLSRELEEISERLEEAGGATSAQIEMNKKREAEFQKMRRDLEEAT 1189
Myh8    EAERASRAKAEKQRSDLSRELEEISERLEEAGGATSAQVEMNKKRETEFQKLRRDLEEAT 1185
Myh3    EAERATRAKTEKQRSDYARELEELSERLEEAGGVTSTQIELNKKREAEFLKLRRDLEEAT 1183
Myh6    EAERTARAKVEKLRSDLSRELEEISERLEEAGGATSVQIEMNKKREAEFQKMRRDLEEAT 1184
Myh7    EAERTARAKVEKLRSDLSRELEEISERLEEAGGATSVQIEMNKKREAEFQKMRRDLEEAT 1182
Nmmyh9  ESERASRNKAEKQKRDLGEELEALKTELEDTLDSTAAQQELRSKREQEVSILKKTLEDEA 1180
Myh1    LQHEATAATLRKKHADSVAELGEQIDNLQRVKQKLEKEKSEMKMEIDDLASNMEVISKSK 1249
Myh8    LQHEATAAALRKKHADSVAELGEQIDNLQRVKQKLEKEKSELKMEIDDLSSNAEAIAKAK 1245
Myh3    LQHEATVATLRKKHADSAAELAEQIDNLQRVKQKLEKEKSEFKLEIDDLSSSVESVSKSK 1243
Myh6    LQHEATAAALRKKHADSVAELGEQIDNLQRVKQKLEKEKSEFKLELDDVTSNMEQIIKAK 1244
Myh7    LQHEATAAALRKKHADSVAELGEQIDNLQRVKQKLEKEKSEFKLELDDVTSNMEQIIKAK 1242
Nmmyh9  KTHEAQIQEMRQKHSQAVEELADQLEQTKRVKATLEKAKQTLENERGELANEVKALLQGK 1240
Myh1    RGKQAFTQQIEELKRQLEEEIKAKSALAHALQSSRHDCDLLREQYEEEQEAKAELQRAMS 1369
Myh8    RSKQASTQQIEELKRQLEEETKAKNALAHALQSSRHDCDLLREQYEEEQEGKAELQRALS 1365
Myh3    RSKQAFTQQIEELKRQLEEENKAKNALAHALQSSRHDCDLLREQYEEEQEGKAELQRALS 1363
Myh6    RGKLSYTQQMEDLKRQLEEEGKAKNALAHALQSSRHDCDLLREQYEEEMEAKAELQRVLS 1364
Myh7    RGKLTYTQQLEDLKRQLEEEVKAKNALAHALQSARHDCDLLREQYEEETEAKAELQRVLS 1362
Nmmyh9  KDFSALESQLQDTQELLQEENRQKLSLSTKLKQMEDEKNSFREQLEEEEEAKRNLEKQIA 1360
Myh1    KANSEVAQWRTKYETDAIQRTEELEEAKKKLAQRLQDAEEHVEAVNAKCASLEKTKQRLQ 1429
Myh8    KANSEVAQWRTKYETDAIQRTEELEEAKKKLAQRLQAAEEHVEAVNAKCASLEKTKQRLQ 1425
Myh3    KANSEVAQWRTKYETDAIQRTEELEEAKKKLAQRLQDSEEQVEAVNAKCASLEKTKQRLQ 1423
Myh6    KANSEVAQWRTKYETDAIQRTEELEEAKKKLAQRLQDAEEAVEAVNAKCSSLEKTKHRLQ 1424
Myh7    KANSEVAQWRTKYETDAIQRTEELEEAKKKLAQRLQDAEEAVEAVNAKCSSLEKTKHRLQ 1422
Nmmyh9  TLHAQVTDMKKKMEDGVGCLETAEEAKRRLQKDLEGLSQRLEEKVAAYDKLEKTKTRLQ- 1419
putative S2/LMM hinge region
putative S2/LMM hinge region
Figure 22: Conserved phosphorylation sites of myosin heavy chains. The sequence 
of Myosin binding region between ~950 and ~1420 bp comprises conserved localisation 
of phosphorylation sites (marked in boxes). The known phosphorylations of serine and 
threonine are labelled in red. The hinge region between the S2 fragment and the light 
meromyosin (LMM) region is marked in grey (Lu and Wong, 1985). The sequence of non-
muscle myosin heavy chain 9 (Nmmyh9) served as control.
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are located on MHC that could be influenced by Lrrc39 binding, the protein sequence was 
further analysed by bioinformatical means. Within the Lrrc39 binding areas on myosin 
heavy chains, a highly conserved pattern of mapped phosphorylation sites (Phosphosite.
org) were detected. As shown in Figure 22, several predicted phosphorylation sites were 
identified within the binding region. 
To investigate whether Lrrc39 interaction could influence these identified phosphorylation 
sites, potential changes in the phosphorylation pattern were investigated. Hek293T 
cells were co-transfected with tagged version of Lrrc39 and the binding region of 
myh1fused to GFP. Gamma-ATP supplementation in vitro allows the detection of general 
phosphorylation. After immunoprecipitation of GFP, the phosphorylation status of the 
MHC binding region changed significantly depending on the presence of Lrrc39 (Figure 
23). 
Figure 23: Alteration of phosphorylation status through Lrrc39 binding. Hek293Tcells expressing 
Myh1-GFP fragment with Lrrc39-V5 (first lanes) or Control vector (second lanes). A: Coomassie staining 
showed the Myh1-fragment at 100 kDa band size in equal amounts of loaded proteins. B: Darker bands 
represent increased 32P incorporation to show phosphorylation level C: Western blot against V5 detects 
Lrrc39 fusion protein.
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Altogether, the binding partner analysis of Lrrc39 results in the protein myosin 
heavy chain, which was identified by Yeast-two-Hybrid screen, confirmed through 
immunoprecipitations and the predicted structural view completes the picture. Given the 
recent increasing interests in the field of proteomics and modifications thereof of various 
proteins, this phosphorylation of Myh1 by the overexpression of Lrrc39 shed a new light 
on the possible functions of yet uncharacterised modifications of Myh1.
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5.3.4 Differential localisation of the titin M-band region
To investigate the role of the Lrrc39 interaction, the protein was over-expressed in neonatal 
rat cardiomyocytes, using a GFP- fusion protein. In the same experimental setup, different 
subcellular localisations were observed, which was unexpected due to the consistent results 
from the endogenous Lrrc39 localisation study (shown in Chapter 3.1.3)   To minimise any 
potential interference of the GFP-tag regarding protein-protein interaction, three different 
fusion constructs were used. The N-terminal and the C-terminal fusion of GFP as well 
as the N-terminal fusion of V5 and His led to the same result. To summarise the results 
after several repetitions of the transfection with the different constructs, the subcellular 
localisation of Lrrc39 appeared dynamic. The fluorescent signal of the C-terminal fused 
GFP of Lrrc39 was analysed in neonatal rat cardiomyocytes. As shown in Figure 24, the 
protein was localised in the periphery and appeared in a dense and intensive signal at the 
edges of the cell, which was observed likewise in pre-experiments in C2C12 cell line.
In the same experiment the overexpressed Lrrc39 fusion protein was found in a ‘patchy’ 
pattern in the cytoplasm, with a distribution preferentially in the cell periphery (Figure 
24B). The localisation in Figure 24C was equally distributed in the cytoplasm, in relatively 
thick aligning patches. In Figure 24D the signal appeared more structured, in fine repetitive 
lines, which were observed likewise using antibody staining for endogenous Lrrc39.
Counter staining were performed in the same cells using antibody against Titin M8, a 
C-terminal domain of Titin, which is located at the M-region. The expected pattern of 
M8 was observed in untransfected cells, shown in Figure 24E in the upper cell. However, 
in Lrrc39 transfected cells this pattern was disrupted. Instead small aggregates in the 
cytoplasm were detected. To assess whether this unexpected finding holds true for myosin-
binding proteins, counter staining against MyBP-C were performed, shown in Figure 24F. 
The MyBP-C staining pattern showed no difference between Lrrc39 transfected and non-
transfected cell. Apart from this, the normal staining pattern of MyBP-C in the C-zone 
of the thick filament alternated, with the fine structured signal of the Lrrc39-eGFP fusion 
protein, indicating that overexpression of Lrrc39 prevented a specific interaction of MHC 
with the M8 domain of titin, but did not disrupt all protein-protein interactions of MHC 
in the M-region. 
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Lrrc39-eGFP
Lrrc39-eGFP
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Figure 24: Effect of Lrrc39 overexpression in neonatal rat cardiomyocytes. A- D: Diverse expression 
patterns of Lrrc39-GFP fusion protein suggest dynamic localisation (scale bar: 10 µm). E: Overexpression 
of Lrrc39 correlated with disruptions of the c-terminal end of titin, stained with titin M8 antibody; F: 
Staining pattern of MyBP-C was not influenced by Lrrc39 overexpression (scale bar: 30 µm).
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The overexpression of Lrrc39 in neonatal rat cardiomyocytes results in two main 
observations: First, the subcellular localisation of Lrrc39 fusion-protein appeared in 
different patterns. And second, increased expression of the protein correlated with 
disruption of Titin M8 expression pattern. The latter observation suggests that Lrrc39 
might have occupied the required space of titin M8, which in turn, disrupts its normal 
expression.
To sum the results, Lrrc39 is an evolutionary conserved gene, which is highly expressed 
in the muscle structures (e.g. heart and skeletal muscle). The Lrrc39 protein is necessary 
for proper development of zebrafish larvae and has to be maintained within a narrow 
concentration range as shown by loss- and gain-of-function experiments. As demonstrated 
Lrrc39 resides in the M-band and interact with MHC. Such interaction was visualized by 
computational simulations. One possible outcome of this interaction is the control of 
phosphorylation of myosins, which may affect the proper function of the muscles.
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 „Die Wissenschaft fängt eigentlich erst da an interessant zu werden, wo sie aufhört”
“Science starts becoming interesting just where it ends“
Justus Freiherr von Liebig (1803-1873) aus den ‘Chemischen Briefen’
6 DISCUSSION
This study characterises a novel protein of the sarcomere termed Lrrc39 (leucine-rich 
repeat containing protein39). The presented results evaluate its predicted expression 
patterns in heart and muscle tissues by different techniques as follows: RT-PCR and whole 
mount in situ hybridisation experiments revealed the evolutionary-conserved expression 
patterns in the striated musculature. To investigate the functional impact of this gene, loss 
of function experiments in zebrafish were conducted, which revealed disruptions of cardiac 
and skeletal muscle tissues. More specifically, disorientated muscle cells, which were 
reduced in size, were observed. Detailed analysis of structural components by electron 
microscopy exposed disturbed sarcomere organisation. To elucidate the mechanisms 
behind the causes of such phenotypes upon the loss of Lrrc39, transcriptomics and 
proteomics analyses were performed, which indicated expression changes of key proteins 
for the myofibril assembly.  Although OMICS approaches employed here yielded hints 
about the function of Lrrc39, it remains unclear how this protein initiates this changes and 
if the regulations are due to direct interactions or caused by secondary effect. To address 
this point, subcellular localisation studies and protein-protein interaction analysis were 
conducted. Remarkably, the binding partner screening resulted in the identification of the 
α-helical tail region of the well-known structure proteins myosin heavy chain (MHC). 
Although the head domain of MHC proteins has been investigated extensively in regards 
to their motor activity for muscle contraction, the properties of the α-helical tail region 
is less understood. To address this point, the binding site of Lrrc39 to MHC proteins 
was simulated by computation and further tested biochemically in regards to possible 
phosphorylation sites of MHC proteins. Taken the above results together, it can be 
concluded that Lrrc39 is a novel member of sarcomere whose functions are important for 
the development and maintenance of muscle structures. To further elucidate the function 
of Lrrc39 and its impact on the sarcomere, the following aspects will be reconsidered:  1) 
Where exactly is Lrrc39 localised, 2) how does it impact sarcomere assembly, 3) what 
are the effects of the binding between Lrrc39 and MHC and 4) what does this interaction 
means for future investigations of the muscle function?
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6.1 Differential localisation of Lrrc39 in the sarcomere
Lrrc39 was originally identified by in silico screening as heart and muscle enriched 
gene of unknown function (Uchida, Jenniches, 2009). To evaluate this screen, detailed 
sequence alignments of LRRC39 in seven different organisms was performed (Figure 
5), which proved the evolutional conservation of this gene. To validate the expression 
pattern, RT-PCR experiments using 15 adult murine tissues were conducted, which 
resulted in clear detection of Lrrc39 in cardiac and skeletal muscle (Figure 6). Thereby, 
it confirmed the results of the in silico screen. Apart from heart and muscle tissues, the 
expression of Lrrc39 was detected also in eyes and brown adipose tissue (BAT) of adult 
mice. Since this technique is very sensible, the expression in eyes may be caused by 
traces of surrounded ocular muscles, which could not be excluded. Apart from this, a role 
of Lrrc39 in non-muscle cells might be possible. Unlike in any other investigated tissue, 
the RT-PCR experiments detected a shorter isoform of Lrrc39 in the BAT. This finding 
is interesting in the context of skeletal muscle as a recent report (Seale, 2008) suggests 
the common developmental origin and the presence of shared progenitor cells in the BAT 
and skeletal muscle. A further investigation is necessary to understand the function of this 
shorter isoform in the BAT.
Apart from this, the expression of Lrrc39 was observed during development of embryos 
using whole mount in situ hybridisation experiments in mouse embryos (Figure 6) and 
RT-PCR experiments during the early development of zebrafish embryos (Figure 7), 
which were further confirmed by the published results of Thisse et al. (2004) (Figure 7). 
As with the case of all of the above employed techniques, the exact localisation of 
Lrrc39 within the cell is unknown. To address this point, the subcellular localisation 
in primary muscle cells was investigated using an antibody against Lrrc39. Indirect 
immunofluorescence in cardiomyocytes revealed a clear, alternating pattern of Lrrc39 
(Figure 9). Co-stainings with an antibody against α-actinin, which is localised in the 
Z-band, revealed that Lrrc39 does not reside in the Z-band. To understand the localisation 
of Lrrc39, an antibody against myomesin, which is expressed in the M-band, was utilized. 
As shown in Figure 9, the signal of Lrrc39 overlapped that of myomesin to demonstrate 
the localisation of Lrrc39 in the M-band. While this study was underway, another group 
reported the same expression patterns in cardiac cells (Will, 2010), which confirms the 
findings of this study. 
Although the identification of the subcellular localisation of Lrrc39 based on co-staining 
with marker proteins, i.e. myomesin is promising, upon closer inspection, it contradicts to 
the very consistent results of the Yeast-two-Hybrid screen (section 3.3.1), which indicated 
Lrrc39 binding at the S2 region of MHC. This S2 region connects the myosin head domain 
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with the tail domain, which forms the rod of the filament. The opposing orientation of the 
myosin filaments leads to the formation of the bare zone, where only the myosin rod part 
is localised including the centred M-band. Therefore, the S2 region is expected to localise 
everywhere in the thick filament but not in the M-band. As it was shown by Will et al., 
the Lrrc39 antibody does not co-localise with MyBP-C, which is located in the C-zone of 
the thick filament. Regarding this, a closer inspection of the thick filament is necessary:
The M-band is a structure of approximately 100 nm, and the subcellular localisation was 
analysed in this study using antibody staining and confocal microscopy. Given that the 
resolution of this technique is limited by the wavelength of the light and the numeric 
aperture of the objective, a diffraction limit of such assay is 200 nm, which is twice as 
large as ~100 nm for the M-band; thus, smaller structures cannot be distinguished with 
this technique. Therefore, it can be hypothesised that the observed fluorescent signal of 
the Lrrc39 antibody might be misleading as the actual subcellular localisation of Lrrc39 is 
in the proximal region next to the M-band, where the first S2 units appear. One possibility 
to circumvent this technical problem, immuno-electron microscopy could be utilized 
to provide a higher resolution and to allow for a detailed inspection of the subcellular 
localisation of Lrrc39 within the sarcomere. 
Taken together, the above interpretation of results opens up the following interesting 
question to be pursued further:  Why Lrrc39 appears in the thin band next to the centre 
of the myosin filament and not distributed in the complete rest of the thick filament? Two 
possible explanations can be conceivable: a) Lrrc39 is localised exclusively in the P-zone 
of myosin or b) Lrrc39 is localised in all S2 regions distributed among the thick filament, 
but due to the compact structure in the C- and D- zones, the antigen is not accessible for 
antibodies. 
To address the second point, the subcellular localisation studies in neonatal rat 
cardiomyocytes were conducted (Figure 24). Through the usage of Lrrc39-GFP fusion 
proteins, a potential interference with the antigen was bypassed. With this approach, 
Lrrc39 was detected in different localisation patterns: in dense or patchy pattern at the 
edges of the cell to a fine-lined structure in the cytoplasm (described in Chapter 3.3.4). 
The appearance of this defined thin localisation of Lrrc39-GFP fusion protein argues 
against the point that antigens could not have been recognised.  This finding supports 
the following notion: The observed variations in the localisation pattern occur during the 
sarcomere development. Lrrc39 expression starts in the premature myosin filament and 
specifies to the localisation in the P-zone as the sarcomere matures. The antibody staining 
for Lrrc39 in adult cardiomyocytes revealed in the condensed expression at the central 
part of the myosin filament (as shown in Figure 9) and did not give any evidence for 
the broader localisation. To verify this assumption, additional experiments are necessary. 
For example, live-imaging of Lrrc39-GFP fusion protein in transfected cells during their 
differentiation process, may provide an answer to the question of if the localisation 
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of Lrrc39 dynamically changes from the broad pattern at the cell periphery to its final 
position in the thin pattern at the P-zone. If indeed, Lrrc39 localises specifically to the 
MHC P-zone of the mature sarcomere, this protein might be better renamed in Myosin 
binding protein-P (MyBP-P).
Furthermore, the localisation patterns of Lrrc39 in neonatal muscle cells (Figure 24A-
D) resemble those of α-actinin. The protein α-actinin was reported in several studies to 
locate in a plainer pattern at the cell periphery where it scaffolds sarcomere assembly 
and aligns stepwise in fine thin lines (McKenna, 1986; Dabiri, 1997; Gokhin and Fowler, 
2011). Therefore, it is tempting to speculate that Lrrc39, with comparable subcellular 
localisation, might be involved in the important process of the sarcomere organisation. 
6.2 The impact of Lrrc39 on myofibril assembly
To analyse a potential function of Lrrc39 for sarcomere organisation, loss-of-function 
studies in zebrafish were conducted. The phenotypic observations (Chapter 3.2.1) 
resulted in malformations of the heart shape and disorientated cardiac cells (Figure 11), 
disruptions in skeletal muscle tissue in the tail of the zebrafish (Figure 12) and delayed 
formation of the facial musculature, followed by disorientated muscle fibres (Figure 13). 
These phenotypes in different tissues, which contain cross-striated musculatures, argue 
for a general role of Lrrc39 during the development of muscles. The analysis of the fine 
structure on the zebrafish skeletal muscle using electron microscopy provided evidence 
that sarcomere organisation is altered by the absence of Lrrc39 (Figure 14). 
The sarcomere is structured by the actin filaments and the myosin filament. During muscle 
contraction the actin filament slide along the intervening myosin filament, which lead to 
shortening of the I-band as well as of the H-zone. The length of the A-band that reflects 
the myosin filament is not changed. Due to the slightly different sizes in length (actin 
filament ~1 µm each and myosin filament ~1.57 µm) the I-band should be visible even in 
complete contracted sarcomeres. Although the observations in the skeletal muscle (Figure 
14) showed that the length of the sarcomeres was not significantly changed between 
MOCtrl and MOLrrc39, the Z-band of MOLrrc39 appeared diffuse and the I-band surrounding 
the Z-band could not be defined. This observation suggests a larger A-band that may 
explain the reduced size of the I-band. 
To elucidate these changes the proteomics approach (Chapter 3.2.3) was utilised. The 
aged-matched zebrafish skeletal muscle analysis on protein level revealed reduced 
expression of several sarcomeric proteins. Among these proteins, was the skeletal muscle-
specific protease calpain3 (CAPN3). Calpain3 is a muscle specific protease that cleaves 
cytoskeletal proteins at the Z- and M-Band (Taveau, 2003). This property has 
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been shown to be crucial during muscle atrophy. It was reported that reduction of calpain3 
correlates with muscle degradation (Bartoli and Richard, 2005). Also, targeted mutations 
of calpain3 in mice resulted in misalignment of the thick filament (Kramerova, 2004). 
Further, reduced activity of this protein causes a specific form of muscular dystrophy, 
limb-girdle muscular dystrophy 2A (Richard, 1995). 
Apart from this, Si:dkey-16k6.1, a homolog of CapZ (capping protein muscle Z-line) 
was found reduced in the MOLrrc39 embryos. This protein caps actin filaments at barbed 
ends and protects from polymerisation of depolymerisation of actin (Schafer, 1995). 
Reductions of CapZ are associated with a loss of uniform alignment of the actin filament 
(Pappas, 2008). A further protein is N-RAP that scaffolds actin filaments into the early 
premyofibril (Manisastry, 2009). It was reported that actin-binding protein N-RAP, which 
is positioned at the Z-band, modifies the distribution of muscle myosins and non-myosin 
IIb by post-transcriptional modification (Dhume, 2006). The documented reduced 
expression of N-RAP may be responsible for the disruption of sarcomere organisation 
in the MOLrrc39 zebrafish. Furthermore, tropomodulin (Tmod) that was downregulated on 
protein level. Tmod caps the pointed ends of the actin filaments and thereby protects 
the thin filament form polymerisation or depolymerisation. Inhibition of Tmod results in 
elongated thin filaments (Gregorio, 1995). 
Interestingly, in vitro stimulation of actin dynamics using reagents to stimulate either 
polymerisation or depolymerisation correlated with Lrrc39 expression (Figure 8). This 
phenomenon argues for a role of Lrrc39 for actin filament formation and might explain the 
disrupted sarcomere structure of MOLrrc39 zebrafish detected by the electron microscopy 
analysis. These interesting observations can be put together to support the fundamental 
role of Lrrc39 in the sarcomere organisation. 
Alterations of the mentioned actin binding proteins were all associated with changes in 
the Z-band formation. Such changes could interrupt the connection to the sarcolemma of 
cell-cell interactions due to their important role as anchor point for intermediate filaments 
that provide the structural link between sarcomeres. Disrupted Z-bands may cause 
reduced intermediate filament contacts and thereby the contact to the sarcolemma might 
be reduced. The observed alteration of the protein dystrophin supports this course of 
events. Dystrophin connects the sarcomeres to the sarcolemma and showed after loss of 
Lrrc39 in the zebrafish skeletal muscle significant downregulation. Decreased or mutated 
dystrophin causes the muscle diseases Duchenne- or Becker’s muscular dystrophy. This 
may explain the observed ‘dystrophic’ muscle phenotype of the MOLrrc39 zebrafish.
These disarrangements of the sarcomere structure and a reduced contact to the sarcolemma 
may lead to secondary changes in the muscle tissue. Since these changes were observed in 
vivo, secondary and compensatory mechanisms cannot be excluded. Therefore, it remains 
unclear to what extent the regulation of calcium channels are direct effects of Lrrc39 
reduction. The essential role of calcium transport for the muscle cell is beyond question, 
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and it is not surprising that even small alterations significantly influence muscle function. 
(Berchtold, 2000)  The observed reduction of calcium channels may contribute to the 
phenotypic changes in the zebrafish model. Moreover, reductions of all these important 
factors are likely to cause the disruption of the sarcomere organisation. As a cellular 
response to the disturbed assembly, the expression of heat shock proteins (HSP) (Figure 
18) may reflect a general stress reaction (Liu and Steinacker, 2001). 
The increased expression of Hsp90a was observed on transcript as well as protein level. 
Although, HSP are ubiquitous expressed, hsp90alpha1 was demonstrated to play a crucial 
role during the assembly of sarcomeric myosin filaments. In zebrafish experiments, it was 
shown by Shao Jun Du and colleagues that a reduction of this chaperone causes significant 
myosin degradation and increases unc45b expression. Zebrafish developed poorly 
organised myofibrils (Du, 2008). In loss of function experiments of the co-chaperone, 
unc45b was reported with similar effects on myosin assembly (Bernick, 2010). Even 
though, a comparable phenotype was observed after reduction of Lrrc39 in zebrafish, 
investigations documented an increase of hsp90alpha1 and unc-45expression on protein 
level. It seems contradictive to the observations of Du and Bernick. Unfortunately, gain 
of function studies in zebrafish regarding hsp90 were not yet approached. Therefore, it 
remains unclear if the observed imbalance of heat shock proteins caused the alterations 
in thick filament assembly. 
Together these data showed a reduction of important proteins for actin filament assembly 
upon Lrrc39 inhibition. These proteins were shown to be essential for the formation of 
the premyofibrils. Since disruptions in this initial structure may alter the incorporation 
of the myosin filament, and the increased expression of heat shock proteins may support 
misalignments of thick filaments in the developing sarcomere, I would like to conclude that 
Lrrc39 is required for sarcomere assembly. However, electron microscopy and proteomics 
do not reveal whether these changes  were caused directly by Lrrc39 interaction or were 
due to secondary changes.
6.3 Interaction between Lrrc39 and myosin heavy chain
To address a direct role of Lrrc39 in the process of sarcomere assembly, its binding partners 
were screened. As shown in Chapter 3.3.2, the binding of Lrrc39 by Yeast-two-Hybrid 
revealed different sarcomeric muscle myosin heavy chains (MHC) (skeletal muscle as 
well as heart isoforms). This suggested a role in different tissues and is in agreement with 
the observed phenotype in zebrafish. The binding to MHC was validated through different 
approaches: First, the immunoprecipitations in chicken cardiomyocytes (shown in Figure 
20) resulted in the corresponding binding partner, which further proves this interaction. 
After precipitation of Lrrc39, the co-transfected Myh1-fragment as well as endogenous 
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myosins (detected by MF20 antibody) were detected by Western blot analysis. Second, 
the predicted protein structure of Lrrc39 that based on homology modelling revealed in a 
conformation that perfectly matches to the size of the a-helical coiled-coil domain of the 
MHC rod. Third, indirect immunofluorescence of primary isolated muscle cells show co-
localisation of Lrrc39 with the myosin filament in the sarcomere. These results confirm 
the Lrrc39 binding to MHC. More important seems the question, what is the function of 
Lrrc39 at this position? 
Lrrc39 binds to a protruding position on the a-helical coiled-coil tail domain of MHC, 
termed the S2 fragment. This intermediate region connects the myosin head (S1) with 
the rod part of MHC (LMM) and was proposed to act as lever arm of MHC in order to 
connect to the actin filament for contraction. Thereby two joints form one at the S2/S1 
conjunction and a second at the S2/LMM bond. The connections to the S2 fragment were 
proposed to act as hinge region as early as 1969 by H.E. Huxley. These flexible parts 
enable the myosin heads to disconnect from the myosin filament in order to reach the 
actin filament for binding (H.E. Huxley, 1969). S2 regions were described to be loosely 
attached to the MYH rod (McLachlan and Karn, 1982). Studies by Sanford Bernstein 
and colleagues focused on the region between S2 and LMM in Drosophila melanogaster. 
By exchanging the S2 fragment of a fast muscle to one from a slow muscle myosin of 
the flies, they observed profound changes in the myofibrilar organisation and alterations 
in myosin kinetics, such as increased actin affinity or myosin attachment time (Suggs, 
2007). 
By the interaction of Lrrc39 to this important region of the MHC muscle contraction 
might be influenced. Regarding this, the additionally identified interaction partner 
2900073G15Rik (Figure 19) may be of further interest. The 2900073G15Rik gene has two 
homologs in human as well in zebrafish namely myosin light chain 12a and 9, regulatory 
(MLC12 and MLC9). Since the regulatory light chains modulate the movement of the 
myosin heads, an interaction by Lrrc39 seems likely to influence the process and thereby 
a regulation of the myosin-actin interaction might be possible. Indirect evidence form 
Margossian et al. supports this notion: In their experiments they inhibited the hinge region 
S1/S2 by specific antibodies and observed decreased muscle contraction (Margossian, 
1991). 
In sum, the binding to MHC at the S2 region is prone to influence the mobility of the lever 
arm and may cause the myosin head region to stick out in order to reach the actin filament 
for contraction. To understand how Lrrc39 regulates this movement further studies are 
necessary. However, closer inspections of the MHC binding region of Lrrc39 revealed 
conserved phosphorylation sites. This phosphorylation pattern within the binding region 
leads to the question if there could be an active role of Lrrc39?
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6.4 Modification of myosin heavy chain phosphorylation
The documented phosphorylation sites in the Lrrc39 binding region were conserved 
among all MHC binding partners (Figure 22). To investigate whether Lrrc39 interaction 
alters phosphorylation, radiolabelling by	γ-ATP supplementation in co-transfected cells 
was utilised. Transfection of the MHC binding region (myh1-GFP) with or without 
Lrrc39, followed by myh1-GFP precipitation and analysis of the 32P incorporation was 
approached. The co-expression of Lrrc39 resulted in higher signal at the expected band 
size of the constructed myh1 binding region (~100 kDa) and thereby confirmed that 
binding of Lrrc39 leads to higher phosphorylation. Also additional bands were detected 
with increased 32P-incorporation after Lrrc39 binding. Clearly, this experiment needs 
further confirmation and so far, the additional proteins could not be identified. However 
this pilot test showed clearly that Lrrc39 binding increases phosphorylation patterns. Due 
to the unknown kinase that phosphorylates MHC in this region and the unclear function 
of MHC phosphorylation, the precise mechanism of Lrrc39 remains open. One potential 
candidate that may influence this process is the titin kinase domain, which is localised 
in close proximity to Lrrc39 in the M-band region. It was shown that this titin region 
is involved in early muscle formation and severe phenotypes could be observed after 
titin knockout or deficiency in mice, including destroyed sarcomere formation (Pernigo, 
2010). Since the in vitro data of Lrrc39 overexpression (Figure 24E) resulted in a loss of 
the C-terminal region of titin, it might be worthwhile to extent this experiment in order 
to clarify whether the strong increase of Lrrc39 proteins, which may interfere with titin 
binding at this position, or an increase of MHC phosphorylation was the cause of this 
disruption in titin expression pattern. Further, it remains to be determined whether titin 
kinase is altered by Lrrc39 expression. This could be addressed by analysing the titin 
kinase activity in the established in vitro system.  Although the interaction partner of 
Lrrc39 was established and differences in phosphorylation patterns were observed, the 
mechanism how Lrrc39 can influences sarcomere assembly and thereby muscle function 
remains unclear.  
To summarise the presented results of this study and combining the subcellular localisation 
of Lrrc39 with the observed changes in sarcomere assembly and the binding to MHC, 
I propose the following model to elucidate a potential role of Lrrc39 for sarcomere 
organisation. Figure 25 illustrates the localisation of Lrrc39 (green) in the proximal 
M-band region of the thick filament (grey), bound to the S2 region of MHC. The S2region 
was described as lever arm to connect the myosin head to the actin filament (red) in 
order to promote muscle contraction. From the proposed localisation of Lrrc39 in the 
MHC P-zone it can be postulated that the movement of the last myosins influence the 
N-terminus of the actin filament. The striking effect after Lrrc39 inhibition on actin-
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regulate actin elongation, supports this notion. Thereby, myosins in the P-zone may block 
further actin elongation and regulate the alignment of the filaments during sarcomere 
assembly. The loss of Lrrc39 would lead to reduced mobility of the central located 
myosins, followed by uncontrolled elongation of the actin filament and consequently to 
an imbalance of the filament systems. Thereby the extension in which myosin filaments 
slide into actin filaments during contraction is altered.  On the contrary, overexpression 
of Lrrc39 may cause increased movement of the myosin lever arm, which may inhibit 
the actin filament elongation and consequently influence the sarcomere organisation. 
Additionally, the increase of Lrrc39 proteins may impede c-terminal titin binding to the 
M-band. 
M-bandZ-band Z-band
   normal
- Lrrc39
++ Lrrc39
I-band I-bandbare zone
A-band
thin filament
thick filament
titin
Figure 25: Model of hypothetical function of Lrrc39. The schematic drawing shows 
the localisation of Lrrc39 ( ) in the P-zone of the sarcomere positioned on the S2 
region of MHC. Through interference in this region the lever arm is moved towards the 
actin filament (red). The thereby outwards sticking myosin signals the actin filament 
that the end is reached. The absence of Lrrc39 causes reduced ability of the lever arm 
to stick out from the myosin filament (grey).  Myosin in the P-zone fails in signalling 
the actin filament to stop elongating and the both filament systems slide too far into 
each other. On the contrary, overexpression of Lrrc39 may result in enhanced mobility 
of the lever arms in a broader region, which influences filament elongation and may 
lead to reduced contractility. Further, the overexpression may impede the binding of 
the c-terminal end of titin (blue). Both changes might disrupt sarcomere organisation 
and cause secondary changes.
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Since the large protein titin is regarded as a molecular spring that controls the sarcomere 
extension and prevents actin- and myosin filaments from sliding too far away from each 
other. Consequently an opposite mechanism must exist that controls the filaments to not 
slide too far into each other. The proposed model suggests the MHC at the P-zone of the 
myosin filament for this unique function.  From the proposed role on filament assembly, 
it can be postulated that a balanced expression of Lrrc39 is required for normal sarcomere 
assembly.
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6.5 Final conclusion and outlook
The data presented here expand our understanding of the sarcomere architecture. The 
analysed expression patterns and the investigated subcellular localisation of Lrrc39 result 
in a conserved position at the proximal M-region of the striated musculature. Investigations 
of phenotypic changes after loss-of-function experiments in zebrafish provided evidence 
for an impact on muscle development. Further, regulation of actin binding proteins and 
heat shock proteins provided evidence for a distinct role in sarcomere assembly.
One of the most important results of this study is the identification of the interaction 
domain within MHC, which interacts with Lrrc39. The identified S2 region seems crucial 
for the binding between myosin- and actin filament to allow spatially controlled muscle 
contraction. My results localise Lrrc39 to the P-zone of the thick filament. Together with 
the described effects on sarcomere assembly, these data argue for a crosstalk between 
structural assembly and contraction. Previous reports have shown that the integration of 
sarcomeric proteins during assembly correlate with the contraction of the cell (Simpson, 
1993; Fujita, 2007). Therefore it was postulated that contraction is required for a uniform 
and proper arrangement of the sarcomere (De Deyne, 2000). Together with these data, 
it can be postulated that Lrrc39 influence sarcomere assembly by modulation of muscle 
contraction. Further work to understand the mechanisms of Lrrc39-MHC interaction 
is of paramount importance, in particular in terms of MHC phosphorylation in the S2 
region. Further work will focus on the effect of Lrrc39 inhibition on force production. 
The studies of Dou and Arner on zebrafish musculature offer a promising tool for further 
investigations (Dou, 2008) in this respect.
It is important to note, that sarcomere assembly is not only restricted to the early muscle 
development but essential for muscle maintenance, physiological muscle growth and 
under pathological conditions like hypertrophy or remodelling processes after atrophy. 
Given the importance of sarcomere assembly for muscle function, I showed that Lrrc39 
as integral part of the sarcomere with its regulatory properties is worth studying in detail. 
Since the expression analysis of Lrrc39 is not only expressed in early embryonic stage, 
but also in adult cardiac and skeletal muscle tissues, investigations of later developmental 
stages seem promising. To understand the basic function of Lrrc39 and to analyse the role 
in the adult tissue a mouse knock-out project has been initiated. With this model it would 
be possible to investigate the impact on sarcomere assembly during muscle maintenance 
and clarify in vivo whether Lrrc39 regulates muscle function in the adult tissue. 
Apart from this, not all proteins involved in the process of sarcomere assembly have yet 
been characterised. It seems likely that the initial in silico screen, which yielded Lrrc39, 
still holds similarly important proteins. Additional functional studies, similar to the 
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approach presented in this thesis are necessary to explore this possibility, which might be 
important for muscle function. Work in this direction has already been started focusing on 
the LMOD3 and USP28 genes. I trust that the annotation of new genes is an important step 
in order to understand the mechanisms underlying force generation in the musculature.
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